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Abstract 
A novel dual resin based, substrate feed and product removal (SFPR) strategy has been 
investigated to overcome the substrate and product inhibition in an industrially important 
Baeyer-Villiger monooxygenase catalysed bioconversion in order to enhance the 
productivity of the bioconversion process. The bioconversion of the ketone substrate, 
bicyclo[3.2.0]hept-2-en-6-one, to the lactone products, (1R,5S)-3-oxabicyclo[3.3.0]oct-
6-en-2-one and (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one, catalysed by a recombinant 
whole cell biocatalyst, Escherichia coli TOP10 [pQR239], expressing cyclohexanone 
monooxygenase from Acinetobacter calcoaceticus, was used as the model reaction to 
prove the feasibility of the novel dual resin SFPR concept. 
Before the application of the dual resin SFPR strategy to the Baeyer-Villiger 
bioconversion, adsorption of the ketone and lactone onto non-specific resins was 
investigated. Several resins were initially characterised at the bench scale by 
determining adsorption isotherms for the ketone and lactone compounds. Thereafter 
adsorption isotherms were generated via a high throughput resin screening (HTRS) 
method using both 96 wells and 24 wells microplate platforms. 
Comparison of the adsorption isotherm data between the bench scale and the two HTRS 
platforms, together with results of resin mixing in wells of the 96 wells and 24 wells 
microplate platforms, as investigated by high speed imaging experiments, shows that the 
24 well microplate platform was the most suitable to investigate adsorption kinetics of 
the ketone and lactone on the resins. 
Based on the adsorption studies, resins Dowex
®
 Optipore L493 and Amberlite
®
 XAD7 
were chosen to be separately used for substrate feeding in the dual resin SFPR strategy. 
Dowex
®
 Optipore L493 was chosen for its high capacity of 0.21 g/gadsorbent for ketone, 
whereas Amberlite
®
 XAD7 was chosen for its high selectivity of ketone over lactone 
compared to any other resin. Amberlite
®
 IRC50 was chosen for lactone removal in the 
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dual resin SFPR strategy because of its high selectivity of lactone over ketone than any 
other resin. 
To demonstrate the feasibility of the dual resin SFPR strategy, the Baeyer-Villiger 
bioconversion was performed in shake flasks and compared to bioconversions without 
the use of resins and with the use of a single resin based SFPR strategy. At an initial 
ketone concentration of 3g/l, both resin based strategies performed significantly better 
than the bioconversion performed without resins. The dual resin SFPR strategy, carried 
out with both types of resins free in suspension without spatial separation, also showed 
improvement compared to results obtained with the single resin SFPR strategy. The dual 
resin SFPR strategy was also performed with the spatial separation of the two resins by 
housing one of the resins in a porous bag. This allowed observation of the majority of 
lactone product adsorbed onto the Amberlite
®
 IRC50 resin as expected based on 
adsorption studies. 
Carrying out the Baeyer-Villiger bioconversion with the implementation of the dual 
resin SFPR strategy in shake flasks saw an increase of productivity compared to the 
Baeyer-Villiger bioconversions carried out without resins by as much as 132% and in 
comparison with the single resin SFPR strategy by as much 10%, thus demonstrating a 
‘proof of concept’ of the novel dual resin SFPR bioconversion strategy. 
After demonstrating a ‘proof of concept’ for the dual resin SFPR strategy, its application 
in a miniature stirred tank bioreactor was investigated to open the way for scale up 
studies. Two configurations were investigated, namely the conventional reactor system 
where both resins were added directly into the bioreactor, and the recycle reactor system 
where a column housed one of the two types of resins. Using resins with low adsorption 
capacities and the need of an extra resin type in a dual resin SFPR strategy, makes the 
recycle reactor configuration a more attractive system, however it was the conventional 
reactor configuration that performed better than the recycle reactor system. 
The L493-IRC50 combination in the conventional reactor configuration achieves a 21% 
greater productivity than in the recycle reactor. The dual resin SFPR strategy using the 
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L493-IRC50 combination performed better than any other resin based SFPR strategy 
when carried out with both resins in the reactor. It reached a productivity of 0.85g/l/h 
after 2.5 hours of reaction, 5% higher than the productivity achieved with the single 
resin strategy in the conventional reactor configuration. 
The novel dual resin based SFPR strategy and the HTRS method developed in this work 
has the potential to be applied in any bioconversion that needs to overcome substrate and 
product inhibition. 
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Chapter 1. Introduction 
1.1 Prospect of biocatalysis 
A need for more sustainable technologies in the chemical industry has brought 
biocatalysts in the spot-light for application in ‘green chemistry’ (Fahrenkamp-
Uppenbrink, 2002). This is demonstrated by an increasing trend for use of enzymatic 
based bioconversions for the production of fine and bulk chemicals (Straathof et al., 
2002). Particularly, more sustainable methods are actively sought for drug synthesis. 
Initiatives such as the CHEM21 project (http://www.imi.europa.eu/content/chem21) has 
so far received a total of €26.4 million at the half stage of the 2 year project (start date 
01/10/2012), to look into using more common metals instead of rarer and expensive 
precious metals, enzymes, methods to use less solvents and synthetic biology to make 
the drug development process more environmentally friendly. The importance of this 
area is demonstrated by the European participants of the CHEM21 which include 
multinational corporations (e.g. GSK Research and Development Ltd, Sanofi Chimie 
and Pfizer Ltd) from the European Federation of Pharmaceutical Industries and 
Associations (EFPIA), Universities (e.g. University of Manchester, Technische 
Universität Graz and Universität Stuttgart) and also SMEs. 
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Table 1.1 Different technological approaches and measures used by fine chemical, 
pharmaceutical and other related industries towards sustainability (Watson, 2012) 
Solvents 
Using water and ionic liquids as alternative solvents to more toxic 
and harsh DCM, chloroform and dipolar aprotic solvents 
Microwave heating 
Traditionally adopted in medicinal chemistry, microwave heating is 
making its way into process research and development as a result of 
scale-up investigations 
Flow chemistry 
Generally used by non-pharma industry because of operation at larger 
scales and established procedures for handling hazardous reagents 
Avoiding certain 
reagents/reactions 
Companies have started to avoid using certain toxic reagents and 
reactions for safety reasons when there is a suitable alternative. 
Examples include HCN, LiAlH4 and nitrations and Wittig reactions 
 
There is also a demand for effective medicines, i.e. those with few or no side effects and 
high specificity, which means that there will be a need to produce more structurally 
complex molecules (Lye and Woodley, 1999), which can also be fulfilled by 
biocatalysis. Around 200 processes alone are already implemented in the pharmaceutical 
industry (Woodley et al., 2013), with 45% of big pharmaceutical companies having 
dedicated biotransformations group (Watson, 2011). Despite the challenges (see Table 
1.1 above), such a vast application of biocatalysts in the pharmaceutical industry (see 
Table 1.2 below) is seen as a result of the latest wave of technological research and 
innovations, with the pioneering research in molecular biology in the late 1990s being 
the catalyst (Bornscheuer et al., 2012). 
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Table 1.2 Examples of recently developed industrial applications of biocatalysis 
(Bornscheuer et al., 2012; Aldridge, 2013). 
Product (Trade name) Company 
Atorvastatin (Lipitor) Pfizer 
Sitagliptin (Januvia) Merck 
Reboxetine (Edronax) Pfizer 
Simvastatin Codexis 
 
The use of biocatalytic processes as an alternative or as a supplementary tool to 
conventional chemical methods, not only in the sectors mentioned above but also in the 
agrochemicals and food industries, is getting greater attention as the discovery, 
characterisation and application potentials of a range of enzymes expand (Rich et al., 
2002). 
Bioconversions can be performed using either whole-cell or isolated enzymes, 
application of which will be limited by commercial availability, cost (including of the 
process), stability and requirements of reaction, for example the need for regeneration of 
cofactors (Wohlgemuth, 2007). 
The attractiveness of enzymatically driven chemical processes as opposed to 
conventional chemistry include their ability of high stereo-, regio-, chemo- and enantio-
selectivity, to avoid the use of harsh/toxic solvents and the potential of producing 
complex, optically pure molecules in fewer steps as protection and deprotection steps are 
avoided (Bull et al., 1999; Lye et al., 2003; Pollard and Woodley, 2007). As a result, the 
use of biocatalysts for industrial scale asymmetric synthesis, rather than racemic 
resolutions, is becoming more common (Lye and Woodley, 1999; Blaser and Schmidt, 
2004). 
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In spite of the potential and attractiveness of enzyme mediated processes, their 
widespread industrial application remains elusive (Straathof et al., 2002). Several 
reasons can account for this, for example, (1) biocatalytic processes are hindered by 
operation at high substrate and/or product concentrations, (2) biocatalyst longevity, i.e. 
activity of the biocatalyst decreases over time and (3) reaction requirements e.g. 
cofactors. 
1.2 The Baeyer-Villiger oxidation 
1.2.1 Reaction and mechanism 
The chemical conversion of ketones into esters or cyclic ketones into lactones, otherwise 
known as the Baeyer-Villiger (BV) reaction, named after its discoverers, has been 
known for more than a century (Baeyer and Villiger, 1899). 
The mechanism is accepted as being a two-step oxidation with the formation of an 
unstable ‘Criegee intermediate’ after the nucleophilic attack on the ketone by a peracid 
(Figure 1.1) (Criegee, 1948). 
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Figure 1.1 Mechanism of the Baeyer-Villiger reaction (from Kamerbeek et al., 2003). 
1.2.2 Chemical methods 
The BV oxidation is commonly achieved by use of peracid reagents, such as hydrogen 
peroxide (H2O2), m-chloroperbenzoic acid (m-CPBA), peroxybenzoic acid and 
trifluoroperacetic acid (CF3CO3H) (Renz and Meunier, 1999; ten Brink et al., 2004), in 
stoichiometric quantities (Baldwin et al., 2008) which become very hazardous and often 
unstable at industrial level. Another disadvantage of chemical syntheses is that they 
proceed with poor enantioselectivites and enantiomeric excesses (ee) (Baldwin and 
Woodley, 2006). 
Limited success has been achieved by use of metal-based catalysts (Strukul, 1998; 
Watanabe et al., 2002; ten Brink et al., 2004) and metal-free, biomimetic compounds 
(Murahashi et al., 2002) to carry out asymmetric BV reactions. Therefore, for 
application of BV oxidation at industrial scale, oxygen should become the first choice of 
oxidant instead of unstable, toxic and unsustainable peracids mentioned above. 
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1.2.3 Biological methods 
Many researchers (including Mihovilovic, 2006; ten Brink et al., 2004; Kamerbeek et al., 
2003) have recognised enzyme-based, asymmetric BV oxidation as a valuable and 
efficient method, compared to conventional chemical syntheses, to acquire enantiopure 
products (e.g. optically active lactones have been efficiently transformed from racemic 
or prochiral ketones), thus justifying the importance of BV biooxidations in synthetic 
chemistry. 
The most common class of enzyme known to catalyse the BV biooxidation are BV 
monooxygenase (BVMO) and over twenty BVMOs have been identified (Willets, 1997). 
Characterised BVMOs thus far are co-factor dependent flavoproteins and incorporate an 
atom of molecular oxygen into the substrate (Kamerbeek et al., 2003), reaction of which 
proceeds similarly to that of conventional BV oxidation using peracids. 
BVMOs can be categorised into two types: Type I are NADPH- and FAD-dependent 
and Type II enzymes are NADH- and FMN-dependent (Willets, 1997). They have been 
discovered in several organisms, both bacteria and fungi (Table 1.3), catalysing the 
nucleophilic and electrophilic oxygenation of a range of substrates.  
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Table 1.3 Selected BVMOs and their characteristics (Willets, 1997; Kamerbeek et al., 
2003). 
Enzyme 
Microorganism 
Molecular mass 
(kDa) 
Cofactor Coenzyme 
Cyclohexanone monooxygenase 
Acinetobacter calcoaceticus (NCIMB 
9871) 
59 NADPH FAD 
Cyclohexanone monooxygenase 
Nocardia globerula CL1 
53 NADPH FAD 
Cyclopentanone monooxygenase 
Comamonas sp. NCIMB 9872 
200 NADPH FAD 
Cyclododecanone monooxygenase 
Rhodococcus ruber 
67.5 NADPH FAD 
Tridecan-2-one monooxygenase 
Pseudomonas cepacia 
123 NADPH FAD 
Oxocineole monooxygenase 
Pseudomonas flava UQM 1742 
70 NADH FMN 
Diketocamphane monooxygenase 
Pseudomonas putida NCIMB 10007 
78 NADH FMN 
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1.3 Baeyer-Villiger oxidation using Cyclohexanone Monooxygenase 
1.3.1 Cyclohexanone Monooxygenase from Acinetobacter calcoaceticus (NCIMB 
9871) 
Cyclohexanone monooxygenase (CHMO – EC 1.14.13.22) from Acinetobacter 
calcoaceticus (NCIMB 9871) is one of the best characterised BVMOs. It is an FAD-
/NADPH-dependent monomeric protein with a molecular mass of 59kDa and was first 
purified from Acinetobacter and Nocardia species (Donoghue et al., 1976). 
In its wild-type host Acinetobacter, CHMO catalyses the oxidation of cyclohexanone to 
ɛ-caprolactone via the BV mechanism, one of a sequence of catabolic steps of 
cyclohexanol to produce diacid precursors of acetyl-CoA (Secundo et al., 2005). As well 
as ketones and aldehydes, this enzyme is also capable of selective heteroatom 
electrophilic oxygenation, including that of sulphur, phosphorous, selenium and nitrogen 
(Willets et al., 1997; Zambianchi et al., 2002; ten Brink et al., 2004). 
The catalytic mechanism of CHMO has been studied by Ryerson et al. (1982) and Sheng 
et al. (2001) and proceeds as follows (Kamerbeek et al., 2003) (figure 1.2): 
 A reduced enzyme-NADP+ complex is formed from the reduction of the protein-
bound FAD by NADPH. 
 This complex goes on to form a flavin-peroxide as a result of the reaction 
between the enzyme-NADP
+
 complex and oxygen. 
 This initiates the nucleophilic attack by the flavin-peroxide species on the 
carbonyl group of a ketone substrate. 
 Formation of a flavin-hydroxide occurs whilst the Criegee intermediate 
rearranges to the corresponding product. 
 The catalytic cycle is completed with the elimination of water form flavin-
hydroxide, regenerating oxidised FAD and releasing NADP
+
. 
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Figure 1.2 Mechanism of CHMO-mediated oxidation (from Kamerbeek et al., 2003). 
High regio- and enantio-selectivity has been exhibited by CHMO in a natural variant of 
Acinetobacter, TD63 (Alphand et al., 1989). The ketone, bicyclo[3.2.0]hept-2-ene-6-one 
was oxidised, producing two region-isomeric lactones: (-)-(1S,5R)-2-
oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-3-one (an 
unexpected formation and unattainable using conventional chemical methods (Strukul, 
1998)) in a 1:1 ratio and enantiomerically pure (figure 1.3). This work opened the door 
to research of similar substrates which increased the potential of synthetic applications. 
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Figure 1.3 CHMO-mediate bioconversion of bicyclo[3.2.0]hept-2-ene-6-one to its 
corresponding regioisomeric lactones, (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one 
and (-)-(1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-3-one. 
However, use of CHMO at industrial scale in its wild-type form is restricted due to (1) 
Acinetobacter’s pathogenic classification (class 2); (2) the existence of a lactone 
hydrolase (which means an occurrence of undesired side reactions); (3) low enzyme 
productivity, and (4) the need for stoichiometric quantities of cofactor NADPH, which 
makes the use of isolated CHMO undesirable as it necessitates an additional cofactor 
recycling system (Willets, 1997; Doig et al., 2001; Zambianchi et al., 2002). 
Preference is for use of recombinant whole-cell biocatalysts expressing (and 
overexpressing) CHMO as they won’t exhibit any unwanted enzyme activity and 
effectively regenerate and supply cofactors for conversions. As a result, CHMO has 
been cloned and overexpressed into yeast (Stewart et al., 1996; Stewart et al., 1998) and 
E. coli (Chen et al., 1999; Mihovilovic et al., 2001) and have shown to be resourceful, 
performing effective Baeyer-Villiger biooxidations on a range of substrates. 
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1.3.2 Overexpression of Cyclohexanone Monooxygenase in E. coli TOP10 
[pQR239]  
CHMO has been overexpressed in the E. coli strain TOP10 [pQR239], which requires 
the cheap ʟ-arabinose as an inducer, to increase enzyme yield by a factor of 25 (Doig et 
al., 2001). To construct the pQR239 strain, the CHMO gene was cloned from A. 
calcoaceticus (NCIMB 9871) into a pBAD vector and expression put under the control 
of the araBAD promoter (figure 1.4). 
 
Figure 1.4 Plasmid constructs that have led to the construction of pQR2349 (from Doig 
et al., 2001). 
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Expression of heterologous CHMO of 500-600 U/gdcw on cyclohexanone had been 
observed in batch fermentations, with fast growth of E. coli TOP10 [pQR239] to 10 
gDCWl
-1
 (Doig et al., 2001). Further advantages of this expression system for large scale 
BV reactions are the in vivo cofactor recycling system and no unwanted enzyme activity. 
Also, comparative studies by Secundo et al. (2005) showed the recombinant and wild-
type CHMOs to be practically identically, for example, in molecular mass and Km values, 
except in their pH- and thermo-stability, which was attributed to protease contamination. 
Very little in the way of preparative scale biocatalyst BV oxidation can be found. Doig 
et al. (2002) performed a fed-batch, 55 l scale, fermentation process using the 
aforementioned recombinant E. coli, but with increasing product concentration in the 
broth, productivity decreased as a result of an effect of product inhibition on biocatalytic 
activity. 
Further work by the same group (Doig et al., 2003) discovered limitations in rates of 
mass transfer of substrate (bicyclo[3.2.0]hept-2-ene-6-one) across the cell barrier and 
substrate and product inhibition. The optimum substrate concentration was found to be 
between 0.2-0.4 gl
-1
 and of the corresponding products, specific activity of the whole 
cells dropped to zero at lactone concentrations above 4.5-5 gl
-1
. This study (Doig et al., 
2003) produced the combined regioisomeric lactones at a level of 3.5 gl
-1
, in a 45:55 
ratio ((-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one to (-)-(1R,5S)-3-
oxabicyclo[3.3.0]oct-6-en-3-one). Additionally, they exhibited optical purity of 94% and 
99% ee, respectively. 
Recently, Baldwin et al. (2008) achieved a 4.5 gl
-1
 production of the aforementioned 
lactones at a 200 l scale by controlling the substrate concentration in solution. This 
whole-cell BV oxidation is the first at this scale without the use of an auxiliary phase. 
As a result of limited large scale examples, it is important that an efficient and 
applicable preparative scale process needs to be developed to overcome the limitations 
and access the vast number of optically pure compounds produced from bioconversions 
(Alphand et al., 2003). 
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1.3.3 BVMO as the model bioconversion system 
The BVMO class of enzymes has got industrial applications in areas such as antibiotic 
synthesis and demonstrated high regio- and enantio-selectivity but their great potential 
still has to be unlocked. The challenges of inhibition, cell toxicity and substrate 
solubility seen with BVMO bioconversions are factors that make it ideal to be used as 
the model system to evaluate a new dual resin substrate feeding and product removal 
strategy. 
1.4  in situ Substrate Feeding and Product Removal (SFPR) 
1.4.1 General 
As seen with whole cell CHMO-mediated BV oxidation (section 1.3.2), biocatalytic 
processes can be hindered by operation at high substrate and/or product concentrations. 
This can be due to their inhibitory effect on the enzyme, toxicity effect on the whole cell 
or low substrate solubility or a combination of these factors. Poor water-solubility of 
substrate and product can also result in low activity. Therefore, it has become clear that 
for an effective downstream operation and overall process economics there will be a 
need for a strategy that maintains the substrate and product at sub-inhibitory levels 
(Chen et al., 2002). 
A variety of in situ substrate supply and product removal approaches to solve this 
problem has been proposed (Table 1.4). The main objectives for employing such 
techniques are to (1) increase product concentration for easier downstream processing; 
(2) increase yield on biocatalyst, hence reducing biocatalyst cost; (3) increase yield on 
substrate, hence reducing substrate costs; and (4) increase volumetric productivity, 
which reduces reactor volume and processing time (Lye and Woodley, 1999). 
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Table 1.4 Common in situ substrate supply and product removal techniques (Schmid et 
al., 2001). 
Strategy Description 
Conservative liquid 
feed 
Substrate fed into the reactor at limiting rates to prevent 
accumulation. 
Liquid-liquid phase An apolar solvent acts as a substrate reservoir and product sink, 
whilst the cells remain in the aqueous phase. 
Gas-liquid phase Substrate is fed in the gaseous phase and absorbed into the 
aqueous phase where the biocatalyst remains. 
Solid-liquid phase Works by a similar technique to the liquid-liquid phase. 
1.4.2 Resin based SFPR 
The use of macroporous resins for in situ product removal (ISPR) as to resolve the 
problem of product toxicity/inhibition has been applied in bioprocessing (Lye and 
Woodley, 1999; Stark and von Stockar, 2003) and works by extraction of product into 
the solid phase. 
A solid-liquid phase strategy based on the use of an adsorbent polymeric resin has also 
been employed for concomitant substrate supply and product removal. The principle 
method is that the resin adsorbs the substrate before its introduction into the reaction 
mixture. Then mass transfer of the substrate from the resin to the reaction mixture occurs 
according to the adsorption/desorption equilibrium. Enzymatic conversion will yield the 
product which is adsorbed onto the resin, preventing its accumulation around the 
biocatalyst. 
This strategy of in situ substrate feed product removal (SFPR) has been effectively 
applied to ketone reduction (Vicenzi et al., 1997; D’Arrigo et al., 1998; Conceicao et al., 
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2003), sulfoxidation (Zambianchi et al., 2004) and BV oxidation (Hilker et al., 2004a; 
Rudroff et al., 2006). 
Whereas preparative scale BV biooxidation by conservative substrate feeding is a rarity 
(section 1.3.2) and only confined to the analytical scale, kilogram scale bioconversions 
of bicyclo[3.2.0]hept-2-ene-6-one to its corresponding regioisomeric lactones, by the 
recombinant E. coli TOP10 [pQR239] strain, have been demonstrated using the resin-
based SFPR strategy (Hilker et al., 2004a; Hilker et al., 2004b; Rudroff et al., 2006; 
Simpson et al., 2001; Hilker et al., 2005). 
The induction of the resin allowed substrate concentrations of up to 20 gl
-1
 to be used 
while maintaining substrate and product concentrations in the reaction mixture at 
subinhibitory levels (Simpson et al., 2001). 
1.4.3 High throughput resin screening (HTRS) 
The simpler and conservative route of feeding the substrate in concentrated form is more 
attractive for rapid scale up than use of a resin to supply the reactant because of the need 
to screen and select the appropriate resin and evaluate its recycle (Baldwin et al., 2008). 
Therefore an efficient high throughput resin screening (HTRS) methodology needs to be 
designed and implemented in SFPR experiments. 
High throughput processing in the initial phase of development of a biocatalytic process 
allows use of small quantities of biocatalysts, substrates, products, resins and other raw 
materials and enables data to be collected from several, rapid experiments in parallel. 
Key data that a complete HTRS should be able to derive are reaction yield, biocatalyst 
activity and ee, all of which should be a function of substrate/resin ratio. Also, physical 
properties of the resin should be obtained, calculation of maximum substrate loading per 
unit of resin and substrate/product solubility in aqueous reaction bulk at various resin 
concentrations (Kim et al., 2007). 
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High through experimentation has benefited greatly by microwell plate technology 
which has established itself as an analytical tool mainly in enzyme and gene assay 
screenings (Persidis, 1998). However, great strides have been made to apply the 
microwell plate technology to upstream processing as well as other downstream 
processing operations such as in areas of cell culture, microbial (Duetz et al 2000) and 
mammalian (Girard et al 2001), biotransformation studies (Stahl et al 2000) and 
filtration (Jackson et al 2006). 
1.4.4 Choice of reactor for resin based systems 
The choice and configuration of the bioreactor is important for the success of a resin 
based SFPR bioconversion. Also investigations have to be carried out determine whether 
there should be direct or indirect contact between the resins and cell broth (figure 1.5). 
Hilker et al (2004a) tested a “two-in-one” SFPR system in a stirred tank reactor (STR), 
using direct, internal or external modes, and also in a bubble column, with direct and 
internal mode. Bioconversion of bicyclo[3.2.0]hept-2-ene-6-one, by the recombinant E. 
coli TOP10 [pQR239] strain, was carried out at the 1L scale. The bubble column 
configuration gave the best results which suggested that good aeration was one of the 
key factors. 
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Figure 1.5 Schematic showing internal and external modes of SFPR with direct and 
indirect cell contact (from Woodley et al., 2008). 
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1.5 Thesis Aims 
This project aims to address the limitations of biocatalytic processes, specifically the 
inability of efficient operation at high substrate and product concentrations and strategies 
available to overcome this problem. 
The examples of resin-based substrate supply and product removal mentioned in section 
1.4.2 are all “two-in-one” resin-based methodologies, i.e. a single type of resin acts as 
the substrate reservoir and product sink. The work presented in this thesis proposes a 
new concept that uses a “dual resin” strategy. The principle method of deliverance of 
substrate to and removal of product from the broth is identical to that in “two-in-one” 
resin-based strategies, expect that two different types of resins are used. 
One type of resin is preloaded with the substrate and then added to the reaction system 
together with a second type of resin. This second type of resin does not have the 
substrate or another compound adsorbed, it acts as the sink for the product of the 
bioconversion (figure 1.6). The aim behind employing two resins instead of one is to 
exploit the differences in capacity, affinity and general compatibility of resins to 
different compounds. 
The work presented in this thesis aims to demonstrate this novel dual resin based 
substrate feed- product removal (SFPR) concept to overcome both substrate and product 
inhibition that is exhibited in the oxidative Baeyer-Villiger bioconversion, using the 
recombinant whole cell biocatalyst Escherichia coli TOP10 [pQR239] expressing 
cyclohexanone monooxygenase. 
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Figure 1.6 Schematic of dual resin SFPR concept 
Chapter 3 aims to identify the best combination of resins to be used in the dual resin 
SFPR strategy by systematically evaluating different resin combinations to generate 
adsorption isotherms for substrate and product. This chapter further aims to develop a 
high throughput resin screening method that will assist in rapid determination of 
adsorption kinetics. 
Chapter 4 aims to demonstrate a ‘proof of concept’ of the novel dual resin SFPR strategy 
by implementing the strategy at the bench scale in shake flasks by using data from the 
previous chapter that determined the best combination of resin to be employed in this 
strategy. 
Chapter 5 aims demonstrate a ‘proof of concept’ of the novel dual resin SFPR strategy 
by implementing the strategy in a miniature stirred tank bioreactor. This investigation 
will be performed using two reactor configurations and will highlight limitations for 
further development, optimisation and scale up studies. 
 
Resin 1 Resin 2 
E. coli TOP10 
[pQR239] 
Desorption Adsorption 
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Chapter 2.  Materials and Methods 
2.1  Materials 
2.1.1 Chemicals 
Yeast extract, sodium chloride, ampicillin sodium salt, peptone, L(+)-arabinose, 
monosodium phosphate (monohydrate), disodium phosphate (heptahydrate), (±)-cis-
bicyclo[3.2.0]hept-2-en-6-one and (1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-2-one were all 
obtained from Sigma-Aldrich, Agar Technical (Agar No. 3) was obtained from Oxoid 
and  Glycerol and Ethyl acetate were obtained from Alfa Aesar. 
2.1.1.1 Preparation of ketone and lactone solutions in buffer 
Bicyclo[3.2.0]hept-2-en-6-one and (1R,5S)-2-oxabicyclo[3.3.0]oct-6-en-3-one solutions 
were prepared by dissolving them at the required concentration in 50mM phosphate 
(monobasic, dibasic sodium phosphate) buffer at pH 7 (solubility: ketone 15.5g/l 2.7%; 
lactone 54.1g/l 0.9%) to be used for resin screening and bioconversions.  
2.1.1.2 Fermentation media composition 
Fermentation media for the growth of E. coli TOP10 [pQR239] composed of 10g/l of 
yeast extract, sodium chloride, peptone and glycerol (sterilised by autoclaving at a 
temperature of 121C for 20 minutes) and 50mg/l ampicillin sodium salt (added after 
sterilisation through a 0.2µm Minisart
®
, non-pyrogenic, sterile, single use filter unit). 
2.1.2 Resins 
Dowex
®
 Optipore L493, Amberlite
®
 XAD7, Amberlite
®
 IRC50 (Sigma-Aldrich), 
Amberlite
®
 XAD4, Amberlite
®
 XAD1180, Amberlite
®
 XAD16 (Alfa Aesar) were all 
ready to use from packaging, without any pre-treatment required. 
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2.1.2.1 Resin water content 
Each resin was analysed for its water content by placing resins in a 100C oven and left 
to dry overnight and/or until they achieved a constant weight. They were then weighed 
and their water content was calculated (table 2.1). 
Table 2.1 Water content in six resins screened 
Resin XAD7 IRC50 L493 XAD4 XAD16 XAD1180 
Water content (%) 67.6 51.4 62.7 56.5 67.9 69.2 
 
2.1.3 Microorganism 
Escherichia coli TOP10 [pQR239] was used throughout. This strain was constructed 
according to Doig et al (2001) as described in section 1.3.2 in Chapter 1 and stock 
culture were readily available in-house. 
2.1.3.1 E. coli TOP10 [pQR239] seed stock preparation 
Stock culture of the microorganism was prepared from an individual colony grown 
overnight at 37 C on an agar plate containing growth medium (composed of 10g/l of 
yeast extract, sodium chloride, peptone and glycerol and 50mg/l ampicillin sodium salt). 
This was inoculated into a sterile 1 l shake flask containing 100 ml of the growth 
medium and grown overnight at 37C and 200rpm. The culture was then added to 30 % 
v/v of sterile glycerol solution (final 15 % v/v of glycerol), mixed in aseptically and 1 ml 
aliquots were stored at -80C. 
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2.2 Analytical methods 
2.2.1 Ketone and lactone quantification by gas chromatography (GC)  
2.2.1.1 Sample preparation 
Samples were prepared by adding equal volume of ethyl acetate to the aqueous sample. 
The mixture was then vortex mixed for 30 seconds (determined to be sufficient) in a 1.5 
ml Eppendorf tube, thereafter centrifuged at 13000 rpm for 2 minutes (Biofuge 13, 
Heraeus Sepatech, UK) The top solvent layer was transferred into a glass GC vial, 
diluted appropriately with ethyl acetate, which included 1g/l naphthalene as an internal 
standard, and analysed by GC. 
2.2.1.2 Gas Chromatography Operation and Quantification 
A Perkin-Elmer autosystem XL-2 gas chromatograph (Perkin-Elmer, Connecticut, USA), 
fitted with an AT-1701 column (reverse phase silica, 30 m x 0.54 mm) (Alltech, 
Carnforth, UK), was used for the analysis of ketone and lactone. 1 l samples were 
injected onto the column at 200 C using the integrated autosampler and compounds 
exiting the column were detected by a flame ionisation detector (FID). The oven 
temperature programme included an initial holding step at 100 C for 5 minutes and then 
the temperature was ramped at 10C per minute until it reached 250 C. Data capture 
and analysis was achieved using Perkin-Elmer Nelson Turbochrom

 software. 
The FID response to a particular solute concentration in a sample was measured as an 
integrated peak area on a GC chromatogram. Calibration curves (Figure A1) were used 
to quantify these responses for the ketone and lactone compounds. Bicyclo[3.2.0]hept-2-
en-6-one was used for the ketone standard and (1R,5S)-2-oxabicyclo[3.3.0]oct-6-en-3-
one was used for the lactone standard. For each type of sample the coefficient of 
variance for a single peak area measurement was determined from triplicate 
measurements of ten ketone solutions (concentration range 0.1-1.8g/l) and six lactone 
solutions (concentration range 0.1-1.0g/l), and were found to be no more than 2 %. 
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2.2.2 Dry cell weight (DCW) measurement 
Samples were taken from the fermentation of E. coli TOP10 [pQR239] at different 
stages of its growth. OD measurements were taken of the samples at 600nm (OD600nm) 
using an Ultraspec 1110 Pro UV/Visible spectrophotometer (Amersham Biosciences, 
Buckinghamshire, UK). Samples were filtered on pre-weighed grade GF/F glass 
microfiber filter discs, pore size 0.7µm, using a Millipore
®
 vacuum pump. The filters, 
retaining wet cell paste, were placed and left to dry in a 100C oven overnight and/or 
until they achieved a constant weight. They were then weighed and the DCW calculated 
to produce a calibration curve (figure A2). The coefficient of variance for triplicate 
OD600nm measurements were no more than 0.5% and for triplicate DCW measurements 
coefficient of variance were no more than 0.06%. 
2.2.3 Analysis of ketone and lactone load on resin 
Resins recovered from resin based SFPR bioconversions were separated from the 
bioconversion medium by pumping it through a Buchner funnel. The recovered resins 
were weighed and fully immersed and mixed in ethyl acetate, which included 1g/l 
naphthalene as an internal standard, overnight at 200rpm and room temperature to strip 
the loaded ketone and/or lactone from the resin. Sample was taken and analysed as 
described in section 2.2.1.2. 
Preliminary experiments where resins were loaded with known concentrations of ketone 
and lactone were analysed as above and the coefficient of variance for triplicate 
experiments using all six resins were determined to be no more than 8.2%. 
2.2.4 Measurement of glycerol concentration in bioconversion medium 
A 2ml sample from the bioconversion medium was centrifuged at 13000rpm for 2 
minutes (Biofuge 13, Heraeus Sepatech, Brentwood, UK). The cell pellet was discarded 
but the supernatant retained to be assayed using a glycerol enzymatic test kit 
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(Boehringer-Mannheim Roche/R-Biopharm GmbH, Germany) for the determination of 
glycerol concentration. In this assay NADH oxidation is stoichiometrically linked to the 
amount of glycerol present via three enzyme catalysed reactions. Firstly glycerokinase 
catalyses the phosphorylation of glycerol by adenosine-5’-triphosphate (ATP) to L-
glycerol-3-phosphate. The adenosine-5’-diphosphate formed in this reaction is 
reconverted into ATP by phosphoenolpyruvate with the aid of pyruvate kinase, and 
pyruvate is formed. In the presence of the enzyme L-lactate dehydrogenase, pyruvate is 
reduced to L-lactate by NADH with the oxidation of NADH to NAD. NADH oxidation 
was followed spectrophotometrically by measuring the total difference in absorbance at 
340nm on completion of the above reactions using an Ultraspec 1110 Pro UV/Visible 
spectrophotometer (Amersham Biosciences, Buckinghamshire, UK). The coefficient of 
variance for triplicate glycerol standards solutions of a concentration range 4 to 10g/l 
were no more than 1%. 
2.3 Resin Screening 
2.3.1 Millilitre scale adsorption isotherms 
1% (w/v) of resin (section 2.1.2) was agitated with 10ml of either ketone or lactone, 
prepared as described in section 2.1.1.1, at 250rpm and 37C in an orbital shaker (New 
Brunswick Scientific). Concentrations of ketone and lactone ranged from 0.1-5g/l in 
50mM phosphate buffer (2.9g/l monosodium phosphate, 7.7g/l disodium phosphate). 
After equilibrium was reached samples were analysed as described in section 2.2.1, and 
adsorption parameters calculated. Adsorption isotherm models were generated within 
SigmaPlot
®
 version 10 (Systat
®
, Chicago, USA). 
Preliminary experiments were performed to determine when equilibrium is reached by 
mixing 1% (w/v) of resins with 10ml of ketone or lactone of concentration 5g/l, at 
250rpm and 37C, and taking samples every 1.5 hours. Samples were analysed as 
described in section 2.2.1 to see when solute concentration in aqueous phase becomes 
constant.f 
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2.3.2 High throughput resin screening (HTRS) 
High throughput resin screening (HTRS) was performed using 96 and 24 deep square 
well (DSW) polypropylene microplate platforms (see table 2.2). 
Table 2.2 Dimensions of 96 wells and 24 wells microplate 
Platform Well Width Well Height Well Volume 
96 wells (Becton 
Dickenson, NJ, USA) 
8mm 40mm 2ml 
24 wells (Ritter 
Medical, Germany) 
16mm 40mm 10ml 
 
2.3.2.1 Adsorption isotherms 
1% (w/v) of resin (section 2.1.2) was agitated with either ketone or lactone, prepared as 
described in section 2.1.1.1, at 1000rpm and 37 C on an Eppendorf Thermomixer 
Comfort, which has an orbital shaking pattern and a throw of 3mm (Eppendorf AG, 
Hamburg, Germany). Concentrations of ketone and lactone ranged from 0.1-5g/l and 
volumes of each solution were 1ml in 96 wells microplate and 1.5ml in 24 wells 
microplate. After equilibrium was reached samples were analysed as described in 
section 2.2.1, and adsorption parameters calculated. Adsorption isotherm models were 
generated within SigmaPlot
®
 version 10 (Systat
®
, Chicago, USA). 
Preliminary experiments were performed to determine when equilibrium is reached by 
mixing 1% (w/v) of resins with 1ml in a 96 wells microplate and 1.5ml in 24 wells 
microplate of ketone or lactone of concentration 5g/l, at 1000rpm and 37C, and taking 
samples every hour. Samples were analysed as described in section 2.2.1 to see when 
solute concentration in aqueous phase becomes constant. 
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2.3.2.2 Dual compound adsorption kinetics 
Dual compound adsorption kinetic studies were carried out to determine the selectivity 
of the resins to the ketone and lactone compounds. 1g/l of ketone and lactone were 
mixed together with 1% (w/v) of resin at 1000rpm and 37C and samples taken at 
regular intervals between 30 seconds and five minutes were analysed as described in 
section 2.2.1. 
2.3.3 Investigation of resin suspension behaviour in 96 and 24 wells microplate 
formats using high speed imaging 
2.3.3.1 High speed camera equipment 
The camera equipment was loaned from the Engineering Instrument Pool, which is 
managed by the Science and Technology Facilities Council (STFC) (Rutherford 
Appleton Laboratory, Didcot, UK) on behalf of the Engineering and Physical Sciences 
Research Council (EPSRC). 
A Photron FASTCAM MC-1 high speed monochrome video system was used to record 
high speed videos of resin mixing in a mimic of a single well from 96 and 24 wells 
microplate. Images were recorded with a Nikon 24-85mm zoom lens attached to the 
camera and the following settings: 
 Frame rate: 240 fps 
 Resolution: 512 x 512 
2.3.3.2 Investigation of resin suspension behaviour in mimics of 96 and 24well 
microplate 
Clear acrylic Perspex was used to construct (in-house workshop) mimics of a single well 
from 96 and 24 wells microplates. The mimic well was mounted and secured, alongside 
the Photron FASTCAM MC-1 high speed monochrome video camera, onto a Kuhner 
ShakerX LS-X bench top shaker set-up with a throw of 3mm. 1% (w/v) of resin was 
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added to the mimic wells and mixed at agitation speeds ranging from 325 to 800 rpm. 
Frames were visually analysed to record the number of resins in suspension. 
2.4 E. coli TOP10 [pQR239] fermentation 
2.4.1 Preparation of inoculum  
A 1 ml frozen stock aliquot, as described in section 2.1.3.1, was thawed and inoculated 
into a 500ml unbaffled shake flask containing 100ml of fermentation medium as 
described in section 2.1.1. The shake flask was then incubated overnight at 37 C in an 
orbital shaker (New Brunswick Scientific, Edison, USA) at 200 rpm. 
2.4.2 Shake flask fermentation and CHMO induction 
5% (v/v) of the overnight culture was inoculated into a 1 l baffled shake flask with a 
10% working volume of fermentation medium as described in section 2.1.1. The shake 
flask was then incubated at 37C and 250 rpm in an orbital shaker (New Brunswick 
Scientific, Edison, USA). The progress of the fermentation was followed by taking 
OD600nm measurements, as described in section 2.2.2. When growth of E. coli TOP10 
[pQR239] reached middle of exponential growth concentrated L(+)-arabinose solution 
was added via a 0.2 m filter to a final concentration of 0.1 % w/v, inducing the 
expression of CHMO by the recombinant E.coli TOP10 [pQR239] cells. Fermentation 
continued until stationary phase of growth was reached. 
2.4.3 Cell harvest and storage 
Cell culture from fermentation was harvested as 50ml aliquots and centrifuged for 20 
minutes at 3000g and 4°C (Avanti J-E, Beckman Coulter). Supernatant was discarded 
and the wet cell paste was either resuspended in phosphate buffer to be used 
immediately for bioconversion or stored at -80C. 
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2.5 Shake flask bioconversions 
Shake flask bioconversions were performed in 500ml baffled shake flasks with a 10% 
working volume. E. coli TOP10 [pQR239] cells harvested from fermentation (section 
2.4) were resuspended in 50mM phosphate buffer, concentrated glycerol added to a final 
concentration of 10g/l and bioconversion initiated by the addition of substrate. 
Bioconversions were performed at 37 C and 250 rpm in an orbital shaker (New 
Brunswick Scientific, Edison, USA). Samples were taken at regular intervals and 
analysed as described in section 2.2. 
2.5.1 Bioconversions without the implementation of a SFPR strategy 
Bioconversions performed without the implementation of a SFPR strategy were carried 
out by the addition of ketone, prepared as described in section 2.1.1.1. Bioconversions 
were carried out at initial ketone concentrations of 0.4g/l or 3.0g/l. 
2.5.2 Bioconversion with the implementation of the single resin SFPR strategy 
Based on investigations described in section 2.3, a resin was chosen to be used for the 
implementation of the single resin SFPR strategy in the shake flask bioconversion 
experiments. The required amount of resin was mixed in a solution of ketone overnight 
at 37C and 250 rpm in an orbital shaker (New Brunswick Scientific, Edison, USA) for 
the adsorption ketone on resin. 
Resin loaded with ketone was then added to the resuspended cells and 10g/l glycerol to 
initiate the bioconversion at an initial ketone concentration of 3.0g/l. Samples were 
taken at regular intervals and analysed as described in section 2.2. 
Prior to running the resin based bioconversions, experiments were carried out to see if 
the resins have an adverse effect on the whole biocatalyst. This was done by mixing 20g 
of the resins chosen for use in the resin based bioconversion with 8gDCW/l of whole cells 
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in 50mM phosphate buffer for 6 hours at 37C and 250 rpm in an orbital shaker (New 
Brunswick Scientific, Edison, USA) without ketone or lactone. There was no decrease of 
OD and, after filtering off the resins, there was no adverse effect on the whole cell 
biocatalyst activity. 
2.5.3 Bioconversions with the implementation of the dual resin SFPR strategy 
Based on investigations described in section 2.3, resins were chosen to be used for the 
implementation of the dual resin SFPR strategy in the shake flask bioconversion 
experiments. The required amount of resin, to be utilised for substrate feeding, was 
mixed in a solution of ketone overnight at 37C and 250 rpm in an orbital shaker (New 
Brunswick Scientific, Edison, USA) for the adsorption ketone on resin. 
Controlled experiments performed prior to resin based SFPR bioconversions showed 
that adding as much as 20g of resins to an E. coli TOP10 [pQR239] did not have an 
effect on either the OD or the whole cell biocatalyst activity. 
2.5.3.1 Dual resin SFPR bioconversion without separation of the two types of 
resins 
Resin loaded with ketone was added to resuspended cells and 10g/l glycerol to initiate 
the bioconversion at an initial ketone concentration of 3.0g/l. Based on adsorption 
kinetic studies described in section 2.3.2.2 and reaction kinetics from experiments 
described in section 2.5., set amounts of the second type of resin (used as the product 
removal tool) was added to the reaction system at regular intervals. Samples were taken 
at regular intervals and analysed as described in section 2.2. 
2.5.3.2 Dual resin SFPR bioconversion with separation of the two types of resins 
Bioconversions were performed as described in section 2.5.3.1 but with separation of the 
two types of resins. A filter bag (Teekanne, Dusseldorf, Germany), made of cellulose 
tissue, was used to house the resin used as the substrate feeding tool while the second 
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type of resin was kept free in suspension in the bioconversion medium (figure 2.1). 
Samples were taken at regular intervals and analysed as described in section 2.2. 
 
Figure 2.1 A schematic of the method of employing a filter bag for the separation of two 
types of resins used in the dual resin SFPR strategy 
Controlled experiments performed prior to using the filter bag, to physically separate the 
two types of resins used in the dual resin SFPR bioconversions, showed that solute mass 
transfer from inside the filter bag to outside into phosphate buffer and vice versa, was 
not a limiting factor in the bioconversion. Also loss of ketone and lactone by adsorption 
onto the filter bag from the aqueous phase was only at 0.009g/l and 0.008g/l, 
respectively, from a starting solute concentration of 1g/l. 
  
Fliter bag immersed in 
bioconversion medium 
containing resin used for 
substrate feeding Resin used for product 
removal in bioconversion 
medium, free in suspension 
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2.6 Miniature stirred tank reactor (STR) bioconversions 
2.6.1 Operation of miniature STR system 
The miniature STR system used has been designed and described by Gill et al (2008). 
Selected design and instrumentation features of the miniature STR are as follows: 
 Borosilicate glass vessel (100ml maximum working volume), sealed with a 
stainless head plate 
 Magnetically driven, six-blade miniature Rushton turbine impeller (di = 20mm, 
di/dT = 1/3) with a stirring range of 100-2000rpm 
 Four baffles of width 6mm 
 A sparger fitted with a 15µm stainless steel sinter 
 A standard laboratory rotameter in the range 0-200ml/min to regulated air flow 
rate 
 Online monitoring of DOT and temperature by a polargraphic oxygen electrode 
and a narrow K-type thermocouple, respectively 
Agitation rate and air flow were manually regulated to keep DOT above 10% to ensure 
that bioconversions were not limited by oxygen mass transfer. Controlled experiments 
performed prior to the resin based SFPR bioconversions showed that the resins (amounts 
varying from 2 to 20g) did not have an effect on the DOT and did not interfere with the 
DOT probe at mixing rates between 800 to 2000rpm. 
2.6.2 Bioconversions without the implementation of a SFPR strategy 
Bioconversions performed without the implementation of a SFPR strategy were carried 
out by the addition of ketone, prepared as described in section 2.1.1.1, at the required 
concentration. Stirrer speed and air flow rate were maintained at 2000rpm and 1vvm, 
respectively. Samples were taken at regular intervals and analysed as described in 
sections 2.2. 
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2.6.3 Bioconversion with the implementation of the single resin SFPR strategy 
Based on investigations described in section 2.3, a resin was chosen to be used for the 
implementation of the single resin SFPR strategy in the shake flask bioconversion 
experiments. The required amount of resin was mixed in a solution of ketone overnight 
at 37C and 250 rpm in an orbital shaker (New Brunswick Scientific, Edison, USA) for 
the adsorption ketone on resin. 
Resins loaded with ketone were then added to the resuspended cells and 10g/l glycerol 
to initiate the bioconversion at an initial ketone concentration of 3.0g/l. Stirrer speed and 
air flow rate were maintained at 2000rpm and 1vvm, respectively. Samples were taken at 
regular intervals and analysed as described in sections 2.2. 
2.6.4 Bioconversions with the implementation of the dual resin SFPR strategy 
Based on investigations described in section 2.3, resins were chosen to be used for the 
implementation of the dual resin SFPR strategy in the shake flask bioconversion 
experiments. The required amount of resin, to be utilised for substrate feeding, was 
mixed in a solution of ketone overnight at 37C and 250 rpm in an orbital shaker (New 
Brunswick Scientific, Edison, USA) for the adsorption ketone on resin. 
Resin loaded with ketone was added to resuspended cells and 10g/l glycerol to initiate 
the bioconversion at an initial ketone concentration of 3.0g/l. Based on adsorption 
kinetic studies described in section 2.3.2.2 and reaction kinetics from experiments 
described in section 2.5., set amounts of the second type of resin (used as the product 
removal tool) was added to the reaction system at regular intervals. Samples were taken 
at regular intervals and analysed as described in section 2.2. 
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2.7 Resin based SFPR bioconversions performed in the recycle reactor 
configuration 
2.7.1 Specifications of column 
The Tricorn 5/50 column (GE Healthcare, Buckinghamshire, UK) was used in the 
recycle reactor configuration to implement both single and dual resin SFPR strategies. 
The specifications of the Tricorn 5/50 column are as follows: 
 Inner diameter= 5mm 
 Length= 50mm 
 Operating pressure= 1450psi 
 Operating temperature 4-40C 
The column was packed with the required amount of resin, assembled and connected to 
a peristaltic Pump P-1 (Pharmacia Biotech, Sweden) with PTFE tubing (Bohlender, 
Germany) with an internal diameter of 1mm. 
2.7.2 Preparation of column for use in bioconversion 
The required amount of resin for the resin based SFPR strategies was mixed in a solution 
of ketone overnight at 37C and 250 rpm in an orbital shaker (New Brunswick Scientific, 
Edison, USA) for the adsorption ketone on resin. The resin was packed into the column 
by slowly pouring it into the column as slurry in the ketone solution. The column was 
assembled and ketone solution was drained, ready to be used for resin based SFPR 
bioconversions in the recycle reactor configuration. 
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2.7.3 Set up and operation of the miniature STR in the recycle reactor 
configuration 
The column packed with loaded resin was connected to a peristaltic Pump P-1 
(Pharmacia Biotech, Sweden) and the miniature STR, described in section 2.6.1,with 
PTFE tubing (Bohlender, Germany) with an internal diameter of 1mm. The tubing was 
inserted into the STR through openings, which were sealed by self-sealing septa, on a 
single multi-port on the headplate. This completed the full circuit of column, pump and 
STR (figure 2.2). The STR was operated as described in section 2.6.1 and the circulation 
of the bioconversion medium achieved at a flow rate of 6.4ml/min. 
 
Figure 2.2 Recycle reactor with fixed bed of resins in an external loop. 
2.7.4 Bioconversion with the implementation of the single resin SFPR strategy 
The single resin SFPR strategy implemented in the recycle reactor configuration had the 
resin housed in the column outside the STR and no resins free in suspension inside the 
STR. The bioconversion was initiated by starting the pump (flow rate of 6.4ml/min) to 
Fixed bed of resin Miniature STR 
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circulate the bioconversion medium with cells from the STR, through the packed column 
and back into the STR. Stirrer speed and air flow rate were maintained at 2000rpm and 
1vvm, respectively. Samples were taken at regular intervals and analysed as described in 
sections 2.2. The amount of ketone and lactone loaded onto the resin inside the column 
at the end of bioconversion was analysed by dismantling the column and washing the 
resin out with ethyl acetate. Analysis was the performed as described in section 2.2.3. 
2.7.5 Bioconversion with the implementation of the dual resin SFPR strategy 
The dual resin SFPR strategy implemented in the recycle reactor configuration had the 
resin, which was chosen as the substrate feeding tool, housed in the column outside the 
STR. The second type of resin chosen as the product removal tool was added in set 
amounts at regular intervals into the STR free in suspension. The bioconversion was 
initiated by starting the pump (flow rate of 6.4ml/min) to circulate the bioconversion 
medium from the STR, through the packed column and back into the STR. Stirrer speed 
and air flow rate were manually regulated to ensure DOT was kept above 10%. Samples 
were taken at regular intervals and analysed as described in sections 2.2. The amount of 
ketone and lactone loaded onto the resin inside the column at the end of bioconversion 
was analysed by dismantling the column and washing the resin out with ethyl acetate. 
Analysis was the performed as described in section 2.2.3. 
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Chapter 3. Resin screening 
3.1 Aims 
The aim of this chapter is to characterise resins for selection as part of the dual resin 
SFPR strategy to be employed in the Baeyer-Villiger bioconversion, catalysed by 
CHMO expressed in E. coli. Additionally, high-throughput resin screening (HTRS) will 
also be developed to consider its potential for accelerating resin characterisation.  
3.2 Introduction 
Development of resin based SFPR systems requires an understanding of the interactions 
between the compounds in the biocatalytic reaction and the available resins that can be 
applied in such a system. One way is to generate adsorption isotherms which indicate the 
resin capacity, enable evaluation of performance and parameters to be improved, all of 
which are important in optimising the use of resins in biocatalytic processes. 
However, examining the vast number of resins that have the potential of use in a resin 
based SFPR becomes a time and material consuming exercise, so a high throughput 
resin screening (HTRS) methodology which will pave the way for further development 
and optimisation of this system is needed. 
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Equation [1] 
Equation [2] 
3.3 Theory 
3.3.1 Adsorption capacity 
The adsorption capacity, Qads (g/gadsorbent), was calculated using Equation 1: 
     
         
 
 
Where Ci and Ceq are the initial concentration and concentration at equilibrium (g/l), 
respectively. V is the total volume of solution and M is the mass of resin (g). 
3.3.2 Adsorption isotherm models 
Langmuir isotherm: 
The Langmuir model is the simplest model to describe monolayer adsorption and is 
widely used (Doran, 1995). It is shown in equation 2 where Qmax is the maximum 
loading of adsorbate corresponding to complete monolayer coverage of all available 
adsorption sites. At low adsorbate concentrations the Langmuir model approaches the 
linear model and at high concentrations adsorption approaches the monolayer capacity, 
Qmax. KA is the equilibrium constant. 
     
         
       
 
The assumptions of the Langmuir model are (i) that adsorbed molecules form no more 
than a monolayer on the surface, (ii) each site for adsorption is equivalent in terms of 
adsorption energy and (iii) there are no interactions between adjacent adsorbed 
molecules. In experimental systems one of these assumptions will often not be valid, 
largely because adsorbent surfaces are not homogeneous and adsorbate molecules may 
interact to form multi-layers of adsorption on the adsorbent particle. 
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Equation [3] 
Equation [4] 
Freundlich isotherm: 
Another commonly used adsorption isotherm which attempts to incorporate surface 
heterogeneity is the Freundlich isotherm (Doran, 1995) which is described in equation 3. 
In this case n is a constant which represents the degree of surface heterogeneity and KF 
is an equilibrium constant. 
          
   
 
Constant n can be taken as an indicator of the intensity of adsorption, so a value of n>1 
indicates a favourable adsorption, whereas a value of n<1 indicates an unfavourable 
adsorption. 
The isotherm parameters for Langmuir and Freundlich isotherms are determined from 
their linear forms. The regression coefficient (R
2
) is used to determine the relationship 
between the experimental data and the isotherms. 
3.3.3 Determining selectivity based on initial rate of adsorption 
Selectivity, SK,L, of resin for two different compounds is determined by equation 4, 
where KK is the initial rate of adsorption of ketone and KL is the initial rate of adsorption 
of lactone. 
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3.4 Results 
3.4.1 Bench scale resin screening 
Results from the bench scale adsorption experiments are shown in figures 3.1 to 3.3. The 
most apparent trend of adsorption of ketone and lactone onto the six different resins 
(table 3.1) that can be taken from the graphs is that all six resins have a greater capacity 
for the adsorption of ketone than the lactone compound. This suggests that the less 
soluble ketone substrate exhibits a higher hydrophobic adsorption onto all resins 
compared to the lactone product. 
The adsorption of both ketone and lactone on all six resins can be described by both 
Langmuir and Freundlich isotherm models, which can be visualised on each figure. The 
convex shape of all adsorption isotherms, figures 3.1 to 3.3, for both ketone and lactone 
compounds indicate favourable adsorption, with all isotherms reaching or moving 
towards saturation. 
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Figure 3.1 Adsorption isotherms generated using resins (A) XAD7 and (B) IRC50 for 
the adsorption of (●) ketone and (○) lactone in experiments described in section 2.3.1. 
Lines represent mathematical models fitted to the data as described in section 3.3.2 
(Langmuir isotherm represented by solid and long dashed lines; Freundlich isotherm 
represented by medium dashed and dotted lines). Error bars represent one standard 
deviation based on triplicate experiments. 
A 
B 
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Figure 3.2 Adsorption isotherms generated using resins (A) L493 and (B) XAD4 for the 
adsorption of (●) ketone and (○) lactone in experiments described in section 2.3.1. Lines 
represent mathematical models fitted to the data as described in section 3.3.2 (Langmuir 
isotherm represented by solid and long dashed lines; Freundlich isotherm represented by 
medium dashed and dotted lines). Error bars represent one standard deviation based on 
triplicate experiments. 
A 
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Figure 3.3 Adsorption isotherms generated using resins (A) XAD16 and (B) XAD1180 
for the adsorption of (●) ketone and (○) lactone in experiments described in section 2.3.1. 
Lines represent mathematical models fitted to the data as described in section 3.3.2 
(Langmuir isotherm represented by solid and long dashed lines; Freundlich isotherm 
represented by medium dashed and dotted lines). Error bars represent one standard 
deviation based on triplicate experiments. 
A 
B 
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Table 3.1 summarises the parameters calculated from both Langmuir and Freundlich 
adsorption isotherms shown in Figures 3.1 to 3.3 and compares the adsorption of ketone 
and lactone on all six resins. 
The highest maximum adsorption capacity (Qmax), as determined from the Langmuir 
adsorption isotherm, for the ketone compound was achieved using L493 at 0.383 
g/gadsorbent, and the lowest maximum adsorption capacity was seen using IRC50 at 0.048 
g/gadsorbent. Also a direct positive correlation can be seen between the maximum 
adsorption capacity of all six resins with their surface area, i.e. the larger the surface area 
the greater the adsorption capacity for ketone. 
The same pattern is seen with adsorption of lactone with regards to the highest and 
lowest maximum adsorption capacity, i.e. L493 achieved the highest at 0.152 g/gadsorbent 
and IRC50 the lowest at 0.008 g/gadsorbent. However, unlike the trend seen with the 
adsorption of ketone, no positive relationship is seen between the adsorption of lactone 
and resin surface area. However, a negative correlation is observed between lactone 
adsorption and pore diameter, i.e. the smaller the pore diameter the greater the maximum 
adsorption capacity of resin for the lactone. 
Observation of the equilibrium constants of both the Langmuir and Freundlich isotherms 
and constant n calculated from the Freundlich isotherm, shows no relationship between 
the intensity of adsorption with resin surface area and pore diameter, for both ketone and 
lactone compounds. 
  
 
6
5
 
Table 3.1 Resin properties and derived parameters of Langmuir and Freundlich adsorption models. All resin particles range from 1-
2mm in diameter and are polyaromatics except for XAD7 which is an acrylic ester. 
 
 
 
 
   
 
Langmuir Freundlich 
Resin 
Density 
(g/ml) 
Surface 
area 
(m
2
/g) 
Pore 
diameter 
(Å) 
Compound 
Qmax 
(g/gadsorbent) 
KA KF n 
XAD7 1.24 450 90 
Ketone 0.105 0.967 0.050 1.622 
Lactone 0.077 0.342 0.019 1.398 
IRC50 0.66 - 
300-
3000 
Ketone 0.048 0.781 0.020 1.452 
Lactone 0.008 1.621 0.005 1.893 
L493 1.11 1100 46 
Ketone 0.383 1.381 0.209 2.054 
Lactone 0.152 1.307 0.080 2.507 
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Table 3.1 continued 
 
   
 
Langmuir Freundlich 
Resin 
Density 
(g/ml) 
Surface 
area 
(m
2
/g) 
Pore 
diameter 
(Å) 
Compound 
Qmax 
(g/gadsorbent) 
KA KF n 
XAD4 1.08 725 50 
Ketone 0.265 1.118 0.134 1.906 
Lactone 0.115 0.975 0.054 2.444 
XAD16 1.08 900 100 
Ketone 0.351 0.552 0.120 1.699 
Lactone 0.045 3.677 0.034 4.399 
XAD1180 1.04 600 300 
Ketone 0.313 0.474 0.098 1.670 
Lactone 0.032 3.109 0.024 3.715 
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Another parameter that is important especially for designing a SFPR strategy for the 
Baeyer-Villiger bioconversion is the adsorption capacity of ketone on resin at an 
equilibrium concentration of 0.5g/l because it is above this concentration that 
biocatalysis is inhibited.  
Table 3.2 presents the adsorption capacities for all six resins at an equilibrium 
concentration for ketone of 0.5g/l. It can be seen that resin L493 has the highest capacity 
at 0.21g/gadsorbent and IRC50 the lowest at 0.012 g/gadsorbent at the equilibrium 
concentration for ketone of 0.5g/l. 
Table 3.2 Adsorption capacity of six resins at a ketone equilibrium concentration of 
0.5g/l. 
Resin XAD7 IRC50 L493 XAD4 XAD16 XAD1180 
Qads (g/gadsorbent) 0.035 0.012 0.21 0.11 0.082 0.059 
 
3.4.2 High-throughput resin screening (HTRS) 
3.4.2.1 Charaterisation of resin suspension behaviour analysis using high-speed 
image analysis 
Mixing of resins in both the 96 wells and 24 wells microplates were evaluated using a 
high speed camera. The experiment focused on the degree of suspension of the resins at 
different mixing speeds and was carried out as described in section 2.3.3. 
3.4.2.1.1 Resin suspension: 96 microwell platform 
Figure 3.4 shows still images of mixing of all six resins in the 96 microwell model at 
800 rpm. As can be clearly seen, each resin remained settled at the bottom of the well 
without a single resin bead suspended in the liquid. This indicates that the strength of 
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liquid mixing near the base of the well was not sufficient to suspend the resins in this 
well dimension. 
 
Figure 3.4 High speed camera images of (A) XAD7 (B) IRC50 (C) L493 (D) XAD4 (E) 
XAD16 (F) XAD1180 resins obtained under the following conditions: 800rpm, 3mm 
throw, 0.01g resin, 1ml volume [well geometry displayed in Table 2.2]. 
A B C 
D E F 
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3.4.2.1.2 Resin suspension: 24 microwell platform 
Figure 3.5 charts the maximum percentage of suspension of all six resins in the 24 wells 
microplate mimic up to a maximum mixing speed of 800 rpm, measured by observing 
the number of resin beads suspended out of the total number of resin beads added to the 
well. All six resins achieved suspension in the well at similar agitation speeds. 
XAD1180 resins were able to be suspended at a speed of 325rpm and resins IRC50 and 
L493, which needed greater agitation, were able to achieve suspension at speeds of 
350rpm. 
A similar trend is seen with regards to the optimum speeds required for maximum 
suspension with the exception of one resin, IRC50, where a significant increase of 
agitation is needed before maximum suspension is achieved. Resins XAD4, XAD16, 
XAD1180, XAD7 and L493 (ascending order) achieved maximum suspension in the 
range of 375-450rpm, however, maximum suspension of IRC50 was achieved at 800rpm 
despite it being 35% less dense at 0.66g/ml than the next dense resins (1.02g/ml). An 
explanation for this is the observation of ‘clumps’ of IRC50 beads in the high speed 
images of the well (Figure 3.6). This would result in needing high agitation speeds for 
the breakup of these resin ‘clumps’ and also for the suspension of these resin ‘clumps’.  
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Figure 3.5 Suspension percentages of resins (●) XAD7 (○) IRC50 (▼) L493 (∆) XAD4 
(■) XAD16 and (□) XAD1180 in a well mimic from the 24 well microplate performed 
as described in section 2.3.3. 
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Figure 3.6 High speed camera images of (A) XAD7 (B) IRC50 (C) L493 (D) XAD4 (E) 
XAD16 (F) XAD1180 resins obtained in a well mimic from a 24 wells microplate 
platform under the following conditions: 800rpm, 3mm throw, 0.15g resin, 1.5ml 
volume [well geometry displayed in Table 2.2]. 
  
F E 
D 
C 
B A 
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3.4.3 Determination of adsorption isotherms from microwell experiments 
Figures 3.7 to 3.12 show the results from adsorption of ketone and lactone on all six 
resins in 96 and 24 microwell plates. For the purpose of comparison, adsorption data in 
figures 3.7 to 3.12 are fitted to only the Langmuir model and include the Langmuir 
model for bench scale adsorption. 
The Langmuir adsorption model shows a good fit to the adsorption of both ketone and 
lactone on all six resins when using the 96 and 24 microwell plates. However the 
exception to this is the adsorption of ketone and lactone on IRC50 when using the 96 
microwell platform. The convex shape of all adsorption isotherms, figures 3.7 to 3.12, 
when using either the 96 or 24 microwell plates indicates favourable adsorption, with all 
isotherms moving towards saturation. 
A key observation from figures 3.7 to 3.12 is the large error bars (representing one 
standard deviation) associated with the adsorption data generated using the 96 wells 
microplate platform, particularly when nearing saturation. These large variances in 
adsorption can be attributed to the lack of resin suspension in the wells of the 96 wells 
microplate platform as seen in section 3.4.2.1.1. The adsorption process involves the 
adsorbate attaching itself to the surface of an adsorbent. The greater the exposure of 
adsorbent surface to the adsorbate the high chance of adsorption. Thus without resin 
suspension in the wells, resins will remain settled at the bottom, exposing less surface to 
which the adsorbates, in this case ketone and lactone, can adsorb onto. 
This problem is exacerbated in the adsorption of ketone and lactone on IRC50 in the 96 
wells microplate platform because the IRC50 beads tend to clump together (section 
3.4.2.1.2), hence preventing further exposure of surface area to the solutes and resulting 
in a poor fit to data from the ml-scale adsorption studies. 
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Figure 3.7 Adsorption isotherms generated using XAD7 for the adsorption of (A) 
ketone (B) lactone in the (●) 96 wells and (○) 24 wells microplate platforms in 
experiments described in section 2.3.2.1. Lines represent the Langmuir mathematical 
model fitted to the data as described in section 3.3.2 (solid line determined from ml scale; 
medium dashed line from 96 wells microplate; dotted line from 24 wells microplate). 
Error bars respresent one standard deviation based on triplicate experiments. 
A 
B 
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Figure 3.8 Adsorption isotherms generated using IRC50 for the adsorption of (A) 
ketone (B) lactone in the (●) 96 wells and (○) 24 wells microplate platforms in 
experiments described in section 2.3.2.1. Lines represent the Langmuir mathematical 
model fitted to the data as described in section 3.3.2 (solid line determined from ml scale; 
medium dashed line from 96 wells microplate; dotted line from 24 wells microplate). 
Error bars respresent one standard deviation based on triplicate experiments. 
A 
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Figure 3.9 Adsorption isotherms generated using L493 for the adsorption of (A) ketone 
(B) lactone in the (●) 96 wells and (○) 24 wells microplate platforms in experiments 
described in section 2.3.2.1. Lines represent the Langmuir mathematical model fitted to 
the data as described in section 3.3.2 (solid line determined from ml scale; medium 
dashed line from 96 wells microplate; dotted line from 24 wells microplate). Error bars 
respresent one standard deviation based on triplicate experiments. 
A 
B 
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Figure 3.10 Adsorption isotherms generated using XAD4 for the adsorption of (A) 
ketone (B) lactone in the (●) 96 wells and (○) 24 wells microplate platforms in 
experiments described in section 2.3.2.1. Lines represent the Langmuir mathematical 
model fitted to the data as described in section 3.3.2 (solid line determined from ml scale; 
medium dashed line from 96 wells microplate; dotted line from 24 wells microplate). 
Error bars respresent one standard deviation based on triplicate experiments. 
A 
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Figure 3.11 Adsorption isotherms generated using XAD16 for the adsorption of (A) 
ketone (B) lactone in the (●) 96 wells and (○) 24 wells microplate platforms in 
experiments described in section 2.3.2.1. Lines represent the Langmuir mathematical 
model fitted to the data as described in section 3.3.2 (solid line determined from ml scale; 
medium dashed line from 96 wells microplate; dotted line from 24 wells microplate). 
Error bars respresent one standard deviation based on triplicate experiments. 
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Figure 3.12 Adsorption isotherms generated using XAD1180 for the adsorption of (A) 
ketone (B) lactone in the (●) 96 wells and (○) 24 wells microplate platforms in 
experiments described in section 2.3.2.1. Lines represent the Langmuir mathematical 
model fitted to the data as described in section 3.3.2 (solid line determined from ml scale; 
medium dashed line from 96 wells microplate; dotted line from 24 wells microplate). 
Error bars respresent one standard deviation based on triplicate experiments. 
A 
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Figures A.3 to A.8 (thesis Appendix) show the Langmuir adsorption models as in figures 
3.7 to 3.12 with the addition of 95% confidence interval bands for the Langmuir 
adsorption model determined for the adsorption results from the ml-scale. A confidence 
interval band shows a probability/estimate of the fitted regression lines falling within it 
and the higher the percentage of confidence interval is, the tighter the band will be. In 
the case of figures A.3 to A.8, the percentage of confidence interval is set at 95% and 
those adsorption models, generated from the 96 wells and 24 wells microplate, that fall 
within the band show a very good fit to the adsorption model generated at the ml-scale 
and hence the confidence to use the microplate platforms for HTRS. 
The adsorption models generated in the 24 wells microplate, all fall within the 95% 
confidence interval band as seen in figures A.3 to A.8, however only the Langmuir 
model determine for adsorption of lactone on XAD1180 in the 96 wells microplate 
shows a good fit to the model from the ml-scale. The possible reason for the poor fit of 
adsorption models generated in the 96 wells microplate platform is the same as the one 
alluded to in the discussion at the beginning to this section. The lack of resin suspension 
reduces that surface available to the ketone and lactone to adsorb on to, resulting in poor 
adsorption. 
Table 3.3 summarises the parameters from the Langmuir adsorption isotherm shown in 
figures 3.7 to 3.12 and compares the adsorption of ketone and lactone on all six resins at 
the 96 well, 24 well and bench scales. 
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Table 3.3 Comparison of Langmuir parameters for adsorption on ketone and lactone at 
the three different scales 
  
Bench scale 96 microwell 24 microwell 
Resin Compound 
Qmax 
(g/gadsorbent) 
KA 
Qmax 
(g/gadsorbent) 
KA 
Qmax 
(g/gadsorbent) 
KA 
XAD7 
Ketone 0.105 0.967 0.109 0.614 0.126 0.684 
Lactone 0.077 0.342 0.062 0.380 0.062 0.470 
IRC50 
Ketone 0.048 0.781 0.012 0.721 0.055 0.679 
Lactone 0.008 1.621 0.025 0.230 0.007 3.738 
L493 
Ketone 0.383 1.381 0.205 2.113 0.374 1.143 
Lactone 0.152 1.307 0.101 2.035 0.147 1.407 
XAD4 
Ketone 0.265 1.118 0.220 1.034 0.273 0.980 
Lactone 0.115 0.975 0.084 1.627 0.110 1.007 
XAD16 
Ketone 0.351 0.552 0.240 0.698 0.335 0.526 
Lactone 0.045 3.677 0.071 1.323 0.049 2.943 
XAD1180 
Ketone 0.313 0.474 0.471 0.182 0.394 0.324 
Lactone 0.032 3.109 0.027 3.934 0.039 2.053 
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Adsorption in the 24 wells microplate also demonstrates similar adsorption capacity at a 
ketone equilibrium concentration of 0.5g/l to adsorption capacities found at the ml-scale, 
compared to the 96 wells microplate as can be seen in table 3.4. The difference of 
adsorption capacity between the 24 wells microplate platform and the ml-scale does not 
exceed 12%, however the difference, when using the 96 wells microplate platform, 
ranges from as low as 5% to as high as 91%. 
Table 3.4 Comparison of adsorption capacities of six resins at three different scales, at a 
ketone equilibrium concentration of 0.5g/l 
 
Qads (g/gadsorbent) at Ceq 0.5g/l ketone 
(percentage difference to ml-scale) 
Resin ml-scale 96 microwell 24 microwell 
XAD7 0.035 0.024 (37%) 0.031 (12%) 
IRC50 0.012 0.0045 (91%) 0.012 (0%) 
L493 0.21 0.2 (5%) 0.2 (5%) 
XAD4 0.11 0.082 (29%) 0.1 (9.5%) 
XAD16 0.082 0.061 (29%) 0.076 (7.6%) 
XAD1180 0.059 0.056 (5.2%) 0.054 (8.8%) 
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3.5 Adsorption kinetics studies 
The successful mimic of equilibrium adsorption in the 24 wells miroplate platform and 
the larger variance in adsorption in the 96 wells mircoplate platform, determined the 24 
wells miroplate as the platform to use to perform kinetics studies on all six resins. These 
experiments were performed as described in section 2.3.2.2 to determine the degree of 
selectivity of the resins for one compound over the other by comparing the initial rates 
of adsorption of ketone and lactone on resins. The results will show which type of resin 
is suitable to be used as the substrate feeding tool and which type of resin will be 
effective to be used for product removal in the dual resin SFPR bioconversion strategy. 
Over the course of the Baeyer-Villiger bioconversion, with the conversion of substrate 
and formation of product, there will not be a state of equilibrium with respect to 
adsorption of ketone and lactone on resins. Understanding dynamic interactions of 
substrate and product with resins alongside interactions at equilibrium, i.e. adsorption 
isotherms, would help better design of resin based SFPR bioconversion strategies 
Figures 3.13 to 3.18 show the combined adsorption of ketone and lactone, each at an 
initial concentration of 1g/l, on each of the six resins over time. The data shown in these 
figures are of the initial ketone and lactone load on resin before equilibrium has been 
reached. It is important to add that the concentration of both ketone and lactone in 
solution at the start of the experiment is set as 1g/l because this will not lead to resin 
saturation and therefore the interactions will be based only on the affinity of resin for the 
two compounds and not competition over scarce adsorption sites. 
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Figure 3.13 Time course of the dual compound adsorption of (●) ketone and (○) lactone 
on (A) XAD7 and (B) IRC50 in experiments described in section 2.3.2.2. Error bars 
represent one standard deviation based on triplicate experiments. 
A 
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Figure 3.14 Time course of the dual compound adsorption of (●) ketone and (○) lactone 
on (A) L493 and (B) XAD4 in experiments described in section 2.3.2.2. Error bars 
represent one standard deviation based on triplicate experiments. 
A 
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Figure 3.15 Time course of the dual compound adsorption of (●) ketone and (○) lactone 
on (A) XAD16 and (B) XAD1180 in experiments described in section 2.3.2.2. Error bars 
represent one standard deviation based on triplicate experiments. 
A 
B 
 86 
 
Table 3.5 shows the selectivity of each resin for ketone and lactone. The greatest 
selectivity achieved for ketone is seen with resin XAD7 and resin IRC50 shows greater 
selectivity for lactone than any other resin tested. Overall, resins do demonstrate 
selectivity for one compound of the other. Resins XAD16 and XAD1180 show similar 
affinities for lactone over ketone, whereas resins L493 and XAD4 show similar, but 
slight, selectivity for ketone over lactone. 
Table 3.5 Selectivity for ketone and lactone, as determined by equation 4, for each of 
the six resins 
XAD7 IRC50 L493 XAD4 XAD16 XAD1180 
1.84 0.49 1.04 1.08 0.70 0.76 
 
3.6 HTRS efficiency 
The highlights of the above described HTRS method, in a 24 wells microplate platform, 
are the speed and ease of performing adsorption isotherm (section 3.4.3) and adsorption 
kinetic (section 3.5) studies. The amounts of raw material used in the HTRS are 
significantly less than used for the ml-scale adsorption studies (section 3.4.1), for 
example 98.5% less resin is needed for performing HTRS based on 1% (w/v) of resin. 
This has the significant impact of reducing costs especially when screening the vast 
number of resins that are commercially available. 
Reducing the amount of raw material also reduces the experiments’ footprint and 
simplifies the practicality aspect by bringing numerous experiments together in one 
microplate (which then allows the use of a multichannel pipette). This was crucial when 
performing adsorption kinetic experiments where accurate sampling, with respect to 
timing, is a necessity. 
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Finally, implementing the HTRS method reduces the investigation time by performing 
numerous experiments in parallel and, in the case of adsorption isotherm studies, 
reducing the experiment duration. It needs a minimum of 10 hours to perform adsorption 
isotherm studies at the bench scale but only 3-4 hours using the HTRS method. 
3.7 Conclusions 
This chapter has presented a study of adsorption of ketone and lactone on six different 
resins at three different scales- bench, 96 microwell and 24 microwell platforms. Results 
were fitted to Langmuir and Freundlich adsorption isotherm models and compared. High 
speed image analysis was also performed to get an understanding of mixing of resins in 
the 96 microwell and 24 microwell platforms. 
Out of the six resins, L493 showed the highest maximum adsorption capacity for both 
ketone, 0.38g/gadsorbent, and lactone, 0.15g/gadsorbent. More importantly, the highest 
adsorption capacity for ketone at an equilibrium concentration of 0.5g/l was also seen 
with the L493 resin, 0.21 g/gadsorbent. 
Results from high throughput adsorption studies showed similar trends however greater 
variance was observed with the 96 microwell platform and a more accurate mimicry of 
the bench scale adsorption study from the 24 microwell platform. 
Zhang et al (2008) reported that fluid mixing is more intensive in the 96 microwell 
platform than in the 24 microwell platform, however for the suspension of resins, based 
on resin suspension experiments, better suspension is achieved in the 24 microwell 
platform. 
It was decided to perform kinetics study using the 24 microwell platform, based on the 
equilibrium adsorption experiments and also because the high throughput nature of 
experiments was demonstrated. 
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The kinetics study performed showed the adsorption dynamics of combined adsorption 
of ketone and lactone on all six resins. It was found that resin XAD7 has the greatest 
selectivity for ketone and IRC50 for lactone. 
Thus, from the results generated from the equilibrium adsorption and kinetics studies in 
this chapter, it can be concluded that the best resins to be used for an effective SFPR 
strategy are XAD7 for the desorption of ketone, and IRC50 for the adsorption of lactone. 
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Chapter 4. Demonstrating a ‘proof of concept’ of the novel dual resin 
SFPR strategy in shake flasks 
4.1 Aims 
The objective of this chapter is to design a novel dual resin SFPR strategy for the 
Baeyer-Villiger bioconversion. The performance of the process will be experimentally 
investigated to determine whether employing the dual resin SFPR increases the 
productivity in comparison to bioconversions carried out without resins or using a single 
resin SFPR. 
4.2 Introduction 
The whole cell catalysed Baeyer-Villiger bioconversion’s inability to produce large 
amounts of the lactone at both high concentrations of substrate and product necessitates 
a strategy to overcome these inhibitions. Attempts to implement a resin based strategy 
have successfully resulted in an increase of product concentration. These strategies have 
used a single type of resin either as an ISPR tool or SFPR tool (section 1.4.2). 
The investigation of this chapter is to implement a dual resin SFPR strategy to carry out 
a Baeyer-Villiger bioconversion. This strategy will use two different types of resins, one 
for substrate feeding and the other for product removal. The choice of resins is based on 
the results from the resin screening in the previous chapter. 
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4.3 Results 
4.3.1 Demonstration of substrate inhibition in the BV bioconversion 
Prior to investigation of the dual resin SFPR strategy, the reaction rate for the BV 
bioconversion was determined at initial substrate concentrations of 0.4g/l, where product 
formation is at its optimum (Doig et al, 2003), and 3g/l, 7.5 times larger than the 
optimum substrate concentration. 
Bioconversions were performed in 50mM phosphate buffer with a working volume of 
10% (v/v) after preliminary experiments demonstrated better substrate conversion under 
these conditions than performing the bioconversion in fermentation media, directly after 
cell growth, with a working volume of 20% (figure A.10 in Appendix). Using a buffer as 
the medium for bioconversion gives the benefit of better pH stabilisation and any 
negative effects on the enzymatic or metabolic activity possibly caused by undefined by-
products and/or fermentation media components is eradicated. An additional point to 
mention is that the centrifugation and resuspension of cells caused no damage to the 
cells. 
A lower working volume results in a higher gas-liquid interface to liquid volume ratio, at 
constant fixed rates, thus enabling a larger liquid surface for oxygen transfer for better 
aeration in the culture. A sufficient oxygen supply is particularly important in an 
oxidation reaction such as the Baeyer-Villiger reaction and the improved reaction rate 
seen with decreasing the working volume is in line with the report of effect of limited 
oxygen supply to conversion in this reaction by Baldwin and Woodley (2006). 
Figure 4.1 shows the profile of lactone formation at the above mentioned ketone 
concentrations without resins. It can be observed that an increase in substrate 
concentration has an adverse effect on the rate of lactone production. At the initial 
substrate concentration of 0.4g/l, lactone production is achieved at a rate of 1.52g/l/h 
whereas the rate of lactone formation is dramatically decreased with a starting ketone 
concentration of 3g/l, to a rate of 0.34g/l/h. The whole cell biocatalyst activity at 0.4g/l 
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and 3.0g/l initial ketone concentrations are determined to be 25.5U/gDCW, 0.12%, and 
5.7U/gDCW, 0.16%, respectively. 
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Figure 4.1 Production of lactone by E. coli TOP10 [pQR239] biocatalyst (8gDCW/l) 
using initial ketone concentrations of (●) 0.4g/l and (○) 3g/l, without the use of a resin 
SFPR strategy as described in section 2.5.1. Error bars represent one standard deviation 
based on triplicate experiments. 
This set of experiments demonstrates the substrate inhibition in this bioconversion and 
also sets a bench mark for the resin based SFPR bioconversions. The subsequent resin 
based bioconversions will therefore be carried out with an initial substrate concentration 
of 3g/l to compare their performances with that of the performances of the 
bioconversions without resins. 
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4.3.2 Single resin SFPR strategy 
Hilker et al. (2004a) described a single resin SFPR (using L493 as the resin) to carry out 
a BV bioconversion and deemed it the best example of a ‘highly productive’ strategy for 
this reaction. Thus another bench mark was determined from the single resin strategy 
which is to be compared to the dual resin SFPR strategy. 
Figure 4.2 shows the results from the single resin SFPR strategy to perform the BV 
bioconversion. Specifically, this figure shows the accumulation of both ketone and 
lactone in the aqueous phase and also the adsorbed concentration on L493 (observed as 
vertical bars). The experiment utilised resin L493 (ketone loaded to the capacity of 
0.21g/gresin) which exhibited the highest maximum adsorption capacity and the highest 
adsorption capacity at an equilibrium ketone concentration of 0.5g/l out of the six resins 
investigated in Chapter 3. 
The ketone concentration in the aqueous phase decreased in parallel with lactone 
formation for the first 100 minutes of the reaction and decreased to below 0.5g/l, as 
expected based on the adsorption studies in section 3.4.1. Also, lactone concentration in 
the aqueous phase did not exceed 1.08g/l over the course of the reaction, showing that it 
did not contribute to any reaction inhibition. This demonstrates that both desorption of 
the substrate and adsorption of the product were adequate enough as not to limit the 
reaction by lack of ketone in the aqueous phase and hinder the reaction by an unwanted 
accumulation of lactone. 
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Figure 4.2 Single resin SFPR strategy, with use of L493 (8g/l) resin, for the production 
of lactone by E. coli TOP10 [pQR239] biocatalyst (8gDCW/l) using an initial ketone 
concentration of 3g/l on the resin as described in section 2.5.2. (●) ketone in aqueous 
phase, (○) lactone in aqueous phase, (■) ketone adsorbed on L493 and (■) lactone 
adsorbed on L493. Error bars represent one standard deviation based on triplicate 
experiments. 
There was a linear increase of lactone accumulation on the L493 resin over the 6 hours 
of the reaction however there was not a linear desorption of ketone from L493 as 
expected. The amount of ketone bound to the resin did decrease to 0.81g/l after 2.5 
hours from 3g/l at the start of the reaction but after 4 hours it increased slightly to 
0.87g/l. After 2.5 hours the ketone concentration in the aqueous phase is decreased to ca. 
0.05g/l and became constant indicating an equilibrium state for the reaction has occurred 
which meant that ketone had to re-adsorb onto the resin. The increase in ketone 
accumulation could have suggested a significant experimental error if it was not for the 
fact that ketone and lactone recovery, from both the aqueous phase and resin, at 150, 250 
and 360 minutes remained constant at 85%, the overall ketone concentration decreased 
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in parallel with overall lactone production and by 6 hours ketone accumulation on the 
resin had decreased. 
Overall productivity of lactone using the single resin SFPR strategy was 0.73g/l/h and 
out of the total lactone produced 53% of lactone accumulated on the resin. The whole 
cell biocatalyst activity was determined to be 24.6U/gDCW, 5.2%. 
4.3.3 Dual resin SFPR strategy 
Two combinations of resins were investigated based on the adsorption capacity and 
adsorption kinetic studies in Chapter 3. The first combination used L493 (ketone loaded 
to the capacity of 0.21g/gresin) for the substrate feed as it exhibited the highest capacity 
for ketone and the second combination utilised XAD7 (ketone loaded to the capacity of 
0.0.35g/gresin) to feed the ketone as it exhibited the highest selectivity for ketone. Both 
combinations used IRC50 (amount added to system to the capacity of 0.008 g/gresin) as 
the product removal tool due to its high selectivity of lactone over ketone. 
Preliminary experiments (data not shown) of the dual resin SFPR strategy were carried 
out with the total amount of IRC50, required for product removal, added all at once. 
This resulted in poor conversion to lactone possibly due to ketone being adsorbed faster 
onto IRC50 than the cell uptake rate of the substrate (assumption being that rate of 
substrate conversion is proportional to uptake rate). Therefore a method of sequential 
addition of IRC50 into the system was employed based on the rate of adsorption of 
ketone onto IRC50, 0.198g/gresin/h, determined in section 3.5. However it is important to 
note that adsorption of ketone by IRC50 cannot be completely eliminated. 
Dual resin SFPR strategies were performed using two methods: (1) both resins were free 
in suspension in the aqueous phase and (2) IRC50 was held in a filter bag separated from 
the resin loaded with ketone. The latter method allowed the analysis of solute 
accumulation on each resin used in the dual resin SFPR strategy. 
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4.3.3.1 Dual resin SFPR using two resins free in suspension 
Figures 4.3 and 4.4 show the conversion of ketone to lactone using L493 and XAD7 as 
tools for substrate feeding, respectively. The vertical bars show solute accumulation on 
both the resins used for ketone feeding and product removal. 
Overall productivity of lactone using L493 and XAD7 as the substrate feeding tools in 
the dual resin SFPR strategy were 0.90g/l/h and 0.96g/l/h, respectively. The whole cell 
biocatalyst activity using the L493-IRC50 and XAD7-IRC50 combinations are 
determined to be 22.5U/gDCW, 9.1%, and 23.9U/gDCW, 8.4%, respectively. Lactone 
accumulation on resins in the L493-IRC50 combination was achieved to 85% and with 
the XAD7-IRC50 combination 87% of lactone accumulated onto both resins. 
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Figure 4.3 Dual resin SFPR, with use of L493 (8g/l) and IRC50 (300g/l) as substrate 
and product reservoirs respectively, for the production of lactone by E. coli TOP10 
[pQR239] biocatalyst (8gDCW/l) using an initial ketone concentration of 3g/l, as 
described in section 2.5.3.1. (●) ketone in aqueous phase, (○) lactone in aqueous phase, 
(■) ketone adsorbed on both resins and (■) lactone adsorbed on both resins. 1g of fresh 
IRC50 added every 10 minutes, from t=10mins, to a total of 20g. Error bars represent 
one standard deviation based on triplicate experiments. 
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Figure 4.4 Dual resin SFPR, with use of XAD7 (60g/l) and IRC50 (300g/l) as substrate 
and product reservoirs respectively, for the production of lactone by E. coli TOP10 
[pQR239] biocatalyst (8gDCW/l) using an initial ketone concentration of 3g/l, as 
described in section 2.5.3.1. (●) ketone in aqueous phase, (○) lactone in aqueous phase, 
(■) ketone adsorbed on both resins and (■) lactone adsorbed on both resins. 1g of fresh 
IRC50 added every 10 minutes, from t=10mins, to a total of 20g. Error bars represent 
one standard deviation based on triplicate experiments. 
The aqueous phase concentration of both substrate and product for both experiments 
were low enough to prevent any solute inhibition. However with regards to ketone 
concentration, which was close to zero after ca. 60 minutes, it can be suggested that 
availability of ketone for conversion was a rate-limiting step. Also, the concentration of 
ketone and lactone accumulated on resins in both experiments remained constant from 
2.5 hours onwards and with no increase of lactone concentration in the aqueous phase 
there a possibility that the reaction had stopped before 2.5 hours. Preliminary 
experiments (data not shown) showed that bioconversion is still carried out prior to 2.5 
hours at negligible ketone concentrations. 
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Analysis of glycerol concentration post experiments were carried out to determine if 
there were insufficient amounts of glycerol available for bioconversion to take place. 
Concentrations of 8.1g/l, 15.7%, and 7.6g/l, 16.3%, of glycerol were still available in 
the bioconversion medium when using the L493-IRC50 and XAD7-IRC50 combinations, 
respectively. Doig et al. (2003) stated that below 5g/l of aqueous glycerol concentration 
reduces enzyme specific activity therefore lack of glycerol is not responsible for the 
apparent stoppage of bioconversion. 
Also, after filtering off the aqueous phase from the resins bioconversions were carried 
out at a substrate concentration of 0.2g/l, which showed full conversion and no decrease 
of reaction rate. One explanation for the apparent stoppage of product formation is the 
competition between the resins and cells for the ketone, as mentioned earlier in the 
introduction of section 4.3.3. The ketone in solution will adsorb onto fresh IRC50 resin 
that is sequentially added and also readsorb onto the resin used as the substrate feeding 
tool. 
4.3.3.2 Dual resin SFPR with the substrate feeding resin in filter bag 
Figures 4.5 and 4.6 show the conversion of ketone to lactone using L493 and XAD7 as 
tools for substrate feed, whilst contained in a filter bag, respectively, and IRC50 for 
product removal. The vertical bars show solute accumulation on both the resins used for 
ketone feeding and product removal. 
Separation of the two types of resins helps to analyse each resins’ effectiveness of 
playing the role assigned to them, for example, whether the resin chosen for product 
removal, based on its high selectivity for lactone over ketone, is able to achieve 
complete adsorption of the product during the bioconversion, thus preventing the other 
type of resin from removing the lactone.  
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Overall productivity of lactone for both resin combinations was 0.91g/l/h, whilst the 
whole cell biocatalyst activity using the L493-IRC50 and XAD7-IRC50 combinations 
are determined to be 21.8U/gDCW, 11.1%, and 21.3U/gDCW, 12.3%, respectively. 
Lactone accumulation on resins with the L493-IRC50 combination was achieved to 87% 
and with the XAD7-IRC50 combination 85% of lactone accumulated onto both resins. 
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Figure 4.5 Dual resin SFPR, with use of L493 (8g/l) and IRC50 (300g/l) as substrate 
and product reservoirs respectively, for the production of lactone by E. coli TOP10 
[pQR239] biocatalyst (8gDCW/l) using an initial ketone concentration of 3g/l, as 
described in section 2.5.3.2. (●) ketone in aqueous phase, (○) lactone in aqueous phase, 
(■) ketone adsorbed on L493, (■) lactone adsorbed on L493, (■) ketone adsorbed on 
IRC50 and (■) lactone adsorbed on IRC50. 1g of fresh IRC50 added every 10 minutes, 
from t=10mins, to a total of 20g. Error bars represent one standard deviation based on 
triplicate experiments. 
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Figure 4.6 Dual resin SFPR, with use of XAD7 (60g/l) and IRC50 (300g/l) as substrate 
and product reservoirs respectively, for the production of lactone by E. coli TOP10 
[pQR239] biocatalyst (8gDCW/l) using an initial ketone concentration of 3g/l, as 
described in section 2.5.3.2. (●) ketone in aqueous phase, (○) lactone in aqueous phase, 
(■) ketone adsorbed on XAD7 (■) lactone adsorbed on XAD7, (■) ketone on IRC50 and 
(■) lactone on IRC50. 1g of fresh IRC50 added every 10 minutes, from t=10mins, to a 
total of 20g. Error bars represent one standard deviation based on triplicate experiments. 
The apparent observation from figures 4.5 and 4.6 is the high concentration of lactone 
accumulated on IRC50 (yellow bar). This is the resin chosen, based on the adsorption 
kinetics studies in the previous chapter, for product removal because of its high 
selectivity for the lactone over the ketone. 84% of the lactone accumulated on resins in 
the L493-IRC50 combination was found on IRC50 and as much as 88% of adsorbed 
lactone was present on IRC50 in the XAD7-IRC50 combination. 
As seen with the previous method, where both resins are free in suspension in the 
aqueous phase, overall lactone production stops before 2.5 hours, with a possible 
explanation  mentioned earlier in the introduction of section 4.3.3 
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4.3.4 Comparison of single resin and dual resin SFPR 
Productivities of the experiments have been summarised in table 4.1 to compare the 
performance of the three strategies employed for Baeyer Villiger bioconversion. 
Productivities have been calculated by including the volume of resins in the overall 
productivity, as shown in equation 5 below. 
             
                                                        
        
 
 
Comparison is based on data from the resin based strategies up to 2.5 hours after start of 
experiment, because of the influence that the resins have of re-adsorbing the substrate. 
Using productivity for comparison of the different strategies is based on the aim of 
overcoming decline of reaction rate due to the eventual biocatalyst inhibition at high 
substrate and product concentrations. Comparing productivities will demonstrate 
whether the dual resin strategy overcomes this problem. 
In table 4.1, column 3, an increase in productivity is observed when a resin based 
strategy is employed at an initial substrate concentration of 3g/l. There is also an 
improvement of between 0.04-0.07g/l/h when the dual resin strategy is used instead of 
the single resin strategy, except when using the XAD7-IRC50 resins combination whilst 
employing a filter bag, where there is a decrease of 0.02g/l/h. The largest increase of 
productivity using the dual resin strategy compared to the single resin strategy is 10% 
observed with the L493-IRC50 resins combinations. This demonstrates that the dual 
resin strategy, with this resins combination, produces an improved performance at higher 
substrate and product concentrations than the single resin strategy. 
Table 4.1 also shows, in column 4, the productivities that have been generated without 
taking into account the volume of the resins. This further comparison will show what 
Equation [5] 
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impact an increased amount of resins has when using the dual resin strategy over the 
single resin strategy. There is a similar trend to that mentioned above, that is an increase 
in productivity, when a resin based strategy is employed at an initial substrate 
concentration of 3g/l, is observed. There is also an improvement of between 0.17-
0.23g/l/h when the dual resin strategy is used instead of the single resin strategy. 
When comparing the productivities with and without taking into account the volume of 
resins, there is a drop of as much as 23% (XAD7-IRC50 resins combination in filter bag) 
in the productivities of the dual resin bioconversion when considering the volume of the 
resins. The single resin SFPR strategy requires considerably a smaller amount of resins 
(0.05gLactone/gresin) compared to the dual resin SFPR strategy (0.005-0.006gLactone/gresin) 
simply because of the need of a second type of resin for product removal, which has the 
lowest capacity amongst the resins tested (Chapter 3, table 3.1). At the initial ketone 
concentration of 3.0g/l, the single resin SFPR strategy required 0.6g of resin whereas the 
dual resin SFPR strategy needed 15.6g and 19g of resins for the L493:IRC50 and 
XAD7:IRC50 combinations, respectively. 
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Table 4.1 Comparison of performance of three different strategies to undertake Baeyer 
Villiger bioconversion. Results based on data after 2.5 hours of bioconversion. 
  
Productivity 
(g/l/h) [vol. 
of aqueous 
phase+resins]  
Productivity 
(g/l/h) [vol. 
of aqueous 
phase only] 
Lactone on 
resin 
(g/gresin) 
Resin-free 
0.4g/l* N/A 1.52 N/A 
3g/l N/A 0.34 N/A 
Single resin L493 0.72 0.73 0.05 
Dual resin: free 
in suspension 
L493-IRC50 0.79 0.90 0.006 
XAD7-IRC50 0.76 0.96 0.005 
Dual resin: 
filter bag 
L493-IRC50 0.79 0.91 0.006 
XAD7-IRC50 0.70 0.91 0.005 
(*performed to completion) 
The ratio of lactone accumulated on the resin used for product removal to lactone 
accumulated on the resin used as the substrate feed tool with the dual resin SFPR 
strategy have also been calculated. The XAD7-IRC50 combination demonstrated better 
performance, 7.56g/g, than the L493-IRC50 combination, 5.07g/g, as expected because 
resin XAD7 was chosen for its greater affinity for ketone than lactone based on 
adsorption kinetic studies in section 3.5. 
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Figure 4.7 Calculated mass balances from all bioconversions performed without resins 
(‘0.4g/l’ and ‘3g/l’), with the single resin SFPR strategy (‘L493 single SFPR’) and with 
the dual resin SFPR strategy where both types of resins are free in suspension (‘L493-
IRC50 (free)’ and ‘XAD7-IRC50 (free)’) and where they have been physically separated 
(‘L493-IRC50 (filter bag)’ and ‘XAD7-IRC50 (filter bag)’). Results after 2.5 hours of 
bioconversion. 
The mass balances of all the bioconversions performed in this chapter have been 
calculated and plotted in figure 4.7. Where the bioconversions have been performed 
without resins (with initial ketone concentrations of 0.4g/l and 3g/l), solute recovery was 
at 100%, whereas substrate and product recovery from bioconversions performed with 
the implementation of a resin based SFPR strategy, the calculated mass balances ranged 
from 79% to 85%. 
The error with respect to mass balance seen in the bioconversions where resin based 
SFPR strategies have been employed, can only be an experimental error associated with 
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the use of the resins as the calculated mass balance of both bioconversions without the 
use of resins were 100%. It was observed during the resin based bioconversions that 
resin beads would be thrown up onto the inner walls of the shake flask, by the movement 
of the agitated liquid, and remain stuck on the inner walls away from the aqueous phase. 
This reduced the efficient desorption/adsorption of substrate and lactone and caused 
prevent complete recovery of resins after the bioconversion was stopped. Also the loss 
occurring at every stage of resin use, i.e. the several steps involved from the preparation 
of the resins all the way to the GC analysis of load on resin, would accumulate and 
contribute to the significant loss. 
4.4 Conclusions 
This chapter investigated the feasibility of performing a novel dual resin SFPR strategy 
to overcome substrate and product inhibition in the Baeyer-Villiger bioconversion. 
Using two different types of resin, one for substrate feeding and the other for product 
removal, the performance of the dual resin SFPR strategy was compared to a single resin 
SFPR strategy. 
An increase of product concentration was observed with the dual resin SFPR strategy 
demonstrating the feasibility of this concept. It also gave an enhanced performance 
compared to the single resin SFPR strategy with regards to productivity. However, the 
shortcoming of this strategy was the greater amount of resin needed as a different type of 
resin is included for product removal and also the increased competition between resins 
and cells for the substrate. It was seen that as more fresh resin was sequentially added 
for product removal, it also removed substrate from the aqueous phase and hence the 
bioconversion becoming time dependent as seen by the reaction apparently stopping 
after 2.5 hours. 
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Chapter 5. Miniature stirred tank reactor evaluation of SFPR strategy 
5.1 Aims 
The objective of this chapter is to demonstrate the application of the novel dual resin 
SFPR strategy using a miniature stirred tank reactor (STR) and thus open a route to the 
scale-up of the process. The performance of the strategy is investigated experimentally 
to determine its suitability in a stirred tank reactor and hence whether application of the 
dual resin SFPR strategy increases the lactone concentration which can be achieved in 
this bioconversion with and without a single SFPR strategy. 
5.2 Introduction 
The implementation of the dual resin SFPR strategy in a miniature stirred tank reactor 
and demonstrating process efficiency at this scale would indicate potential for large 
scale application and hence making it an industrially relevant process. 
The application of the dual resin SFPR strategy starts with the choice of process 
configuration, as discussed and shown in Chapter 1. Two simple reactor configurations 
have been investigated; the first configuration houses the two types of resins together 
inside the reactor, free in suspension and the second configuration houses one type of 
resin in a miniature column whilst the second type of resin remains in the reactor, free in 
suspension. 
  
 106 
 
5.3 Results 
5.3.1 Baeyer-Villiger bioconversion 
As with the shake flask experiments (Chapter 4), BV bioconversion were carried out in 
the miniature reactor without the use of a resin SFPR strategy. The initial ketone 
concentrations of 0.4g/l and 3.0g/l set a benchmark to compare with the subsequent resin 
based SFPR experiments. 
Lactone formation in the miniature reactor, at the initial ketone concentrations 
mentioned above, is shown in Figure 5.1. The profiles fit the expected trend seen from 
the shake flask experiments in section 4.3.1, where a decrease in lactone production is 
associated with the increase of starting ketone concentration. At 0.4g/l initial ketone, a 
lactone production rate of 1.80g/l/h is achieved, whereas at starting ketone concentration 
of 3.0g/l, lactone production is reduced to 0.38g/l/h. The whole cell biocatalyst activity 
at 0.4g/l and 3.0g/l initial ketone concentrations are determined to be 30.2U/gDCW, 
0.6%, and 4.1U/gDCW, 6.7%, respectively. 
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Figure 5.1 Production of lactone by E. coli TOP10 [pQR239] biocatalyst (8gDCW/l) 
using initial ketone concentrations of (●) 0.4g/l and (○) 3g/l, without the use of a resin 
SFPR strategy in a miniature STR as described in section 2.6.2. Error bars represent one 
standard deviation based on triplicate experiments. 
5.3.2 Single SFPR strategy 
It was decided that all resin based SFPR bioconversions in this chapter were to be 
stopped after 2.5 hours based on the results of Chapter 4 where no change of lactone 
formation was seen beyond this time point. 
The single SFPR strategy was demonstrated in the miniature reactor by using resin L493 
free in suspension. Figure 5.2 shows the concentrations of both ketone and lactone in the 
aqueous phase and bound onto L493. 
The aqueous concentrations of ketone and lactone remained below the concentrations 
that would inhibit the bioconversion. Aqueous ketone concentration was reduced to 
levels that have been considered negligible from 30 minutes onwards and hence the 
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availability of ketone for conversion is seen as a rate limiting step. Overall productivity 
of lactone, using the single resin SFPR strategy, was 0.82g/l/h and after 2.5 hours 
lactone production reached 68% based on the concentration of lactone in the aqueous 
phase and on the resin. The whole cell biocatalyst activity was determined to be 
27.5U/gDCW, 4.7%. 
Time (mins)
0 20 40 60 80 100 120 140 160
C
o
n
c
e
n
tr
a
ti
o
n
 (
g
/l
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
 
Figure 5.2 Single resin SFPR strategy, with use of L493 (8g/l) resin contained in a 
miniature STR, for the production of lactone by E. coli TOP10 [pQR239] biocatalyst 
(8gDCW/l) using an initial ketone concentration of 3g/l on the resin. (●) ketone in aqueous 
phase, (○) lactone in aqueous phase, (■) ketone on L493 and (■) lactone on L493. 
Experiment performed as described in section 2.6.2. Error bars represent one standard 
deviation based on triplicate experiments. 
A worry of using a resin based strategy in a reactor is the occurrence of settling of the 
resin at the base, however mixing in the reactor was observed to be effective for resin 
suspension as the resin fraction of L493 in this single resin strategy was only 1.2% (w/v). 
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5.3.3 Dual SFPR strategy 
Two basic reactor configurations have been used for the dual resin SFPR strategy. The 
first is the direct introduction of resins into the reactor where the first type of resin that 
holds the substrate is added at the beginning of the reaction followed by the sequential 
addition of the second type of resin to adsorb the product from 10 minutes onwards. 
Figures 5.3 and 5.4 show the conversion of ketone to lactone using L493 and XAD7 as 
tools for substrate feed, respectively and IRC50 as the product removal resin. The 
vertical bars show solute accumulation on both the resins used for ketone feeding and 
product removal. 
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Figure 5.3 Dual resin SFPR, with use of L493 (8g/l) and IRC50 (300g/l) as substrate 
and product reservoirs respectively contained in a miniature STR, for the production of 
lactone by E. coli TOP10 [pQR239] biocatalyst (8gDCW/l) using an initial ketone 
concentration of 3g/l. (●) ketone in aqueous phase, (○) lactone in aqueous phase, (■) 
ketone on resins and (■) lactone on resins. Experiment performed as described in section 
2.6.3. 2g of fresh IRC50 added every 10 minutes, from t=10mins. Error bars represent 
one standard deviation based on triplicate experiments. 
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Figure 5.4 Dual resin SFPR, with use of XAD7 (60g/l) and IRC50 (300g/l) as substrate 
and product reservoirs respectively contained in a miniature STR, for the production of 
lactone by E. coli TOP10 [pQR239] biocatalyst (8gDCW/l) using an initial ketone 
concentration of 3g/l. (●) ketone in aqueous phase, (○) lactone in aqueous phase, (■) 
ketone on resins and (■) lactone on resins. Experiment performed as described in section 
2.6.3. 2g of fresh IRC50 added every 10 minutes, from t=10mins. Error bars represent 
one standard deviation based on triplicate experiments. 
The L493-IRC50 combination fared better than the XAD7-IRC50 dual resin 
combination by generating a productivity of 0.94g/l/h compared to 0.84g/l/h, 
respectively. The lower productivity seen with the XAD7-IRC50 dual resin combination 
can be attributed to the higher overall fraction of resins in the aqueous phase of 37% 
(w/v) in this combination compared to the 31.2% (w/v) in the L493-IRC50 combination. 
This difference resulted in the decoupling of the magnetic stirrer above an agitation rate 
of 1500rpm using the XAD7-IRC50 combination whereas with the L493-IRC50 
combination the agitation rate could be maintained at 2000rpm. In comparison, this 
resulted in less efficient mixing of resins in the XAD7-IRC50 combination and hence a 
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higher proportion of resins left settled at the base of the reactor. Ketone and lactone 
recovery was 5% lower using the XAD7-IRC50 combination compared to the process 
with the L493-IRC50 combination. 
The whole cell biocatalyst activity using the L493-IRC50 and XAD7-IRC50 
combinations are determined to be 23.8U/gDCW, 7.7%, and 25.2U/gDCW,  10.4%, 
respectively. 
5.3.4 Recycle STR SFPR strategy 
The second of the two reactor configurations used to implement the resin based SFPR 
strategy was the recycle reactor configuration. In this configuration the aqueous phase 
was pumped from the reactor to a column housing one type of resin and then recycled 
back into the reactor which held the second type of resin in the case of the dual resin 
SFPR strategy, as described in section 2.7. 
As a filter was not used to prevent cells from circulating in the packed column, there is a 
risk of caking and hence blockage of cell culture circulation through the column. To see 
if caking occurs within the set bioconversion period, 8gDCW/l of whole cells in 50mM 
phosphate buffer (without substrate or product) was continuously circulated through the 
packed column at a flow rate of 6.4ml/min. Flow rate was then monitored to observe for 
any change. Results are presented in figure A.12 (Appendix) and show no significant 
change in flow rate up to 180 minutes, demonstrating that any caking that takes place 
during the course of the set bioconversion time will not reduce time of circulation. 
Figure 5.5 shows the results of implementing the single resin SFPR strategy and figure 
5.6 shows the results of implementing the dual resin SFPR strategy. The L493-IRC50 
combination is the only one of the two combinations for the dual resin SFPR strategy 
from Section 5.3.3 demonstrated here because of practical limitations. 
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The volume capacity of the column was only large enough to house the 1.2% (w/v) 
fraction of L493 needed for the implementation of the resin based SFPR strategy. The 
7.1% (w/v) of XAD7 and 30% (w/v) of IRC50 fractions needed were too high to be 
housed in the miniature column. 
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Figure 5.5 Single resin SFPR strategy, using a combination of a miniature STR and 
miniature column containing L493 (8g/l), for the production of lactone by E. coli TOP10 
[pQR239] biocatalyst (8gDCW/l) using an initial ketone concentration of 3g/l on the resin. 
(●) ketone in aqueous phase, (○) lactone in aqueous phase, (■) ketone on L493 and (■) 
lactone on L493. Experiment performed as described in section 2.7.4. 2g of fresh IRC50 
added every 10 minutes, from t=10mins. Error bars represent one standard deviation 
based on triplicate experiments. 
Figure 5.5 shows ketone and lactone concentrations in the aqueous phase and bound to 
L493 inside the column. Ketone concentration in the aqueous phase is extremely low 
and hence is again considered negligible. A more gradual increase of lactone 
concentration is seen in the aqueous phase compared to that seen in Figure 5.2. Overall 
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productivity demonstrated by this configuration was 0.75g/l/h and a product formation 
of 62% was achieved after 2.5 hours. 
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Figure 5.6 Dual resin SFPR, with use of L493 (8g/l) (housed in a miniature column) and 
IRC50 (300g/l) (free in suspension inside a miniature STR) as substrate and product 
reservoirs respectively, for the production of lactone by E. coli TOP10 [pQR239] 
biocatalyst (8gDCW/l) using an initial ketone concentration of 3g/l. (●) ketone in aqueous 
phase, (○) lactone in aqueous phase, (■) ketone on L493, (■) lactone on L493, (■) 
ketone on IRC50 and (■) lactone on IRC50. Experiment performed as described in 
section 2.7.5. 2g of fresh IRC50 added every 10 minutes, from t=10mins. Error bars 
represent one standard deviation based on triplicate experiments. 
Figure 5.6 shows results from the implemention of the L493-IRC50 combination as the 
dual resin SFPR strategy with the recycle reactor configuration. This configuration 
allows the concentration of ketone and lactone on each type of resin to be displayed. Out 
of the total lactone produced, 73% was adsorbed onto IRC50, the resin seen as the most 
effective for product removal, compared to 15% adsorbed onto L493. Productivity 
improved from 0.75g/l/h in the single resin SFPR system to 0.78g/l/h and hence a 
slightly better yield of 65% was achieved. The whole cell biocatalyst activity using the 
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single resin SFPR and dual resin SFPR strategies in the recycle reactor configurations 
are determined to be 26.3U/gDCW, 7.1%, and 22.8U/gDCW, 11.6%, respectively. 
5.3.5 Comparison of single and dual SFPR strategies 
Table 5.1 below compares productivity and the load of solutes on resin for the different 
strategies. Productivities have been calculated by including the volume of resins 
(Equation 5).  
All resin based SFPR systems in both reactor configurations (column 3) gave better 
performances than without using a resin based SFPR system at an initial ketone 
concentration of 3g/l (productivity= 0.38g/l/h) as seen in the shake flask experiments 
(Chapter 4). 
There is a contrast when comparing the two reactor configurations with the performance 
of the recycle reactor configuration being lower than the configuration where resins are 
directly introduced into the reactor. This is true in regards to both single and dual resin 
SFPR strategies and hence makes the conventional reactor system a more attractive 
option of the two. The L493-IRC50 combination in the conventional reactor 
configuration achieves a 21% greater productivity than in the recycle reactor. 
The dual resin SFPR strategy using the L493-IRC50 combination performed better than 
any other resin based SFPR strategy when carried out with both resins in the reactor. It 
reached a productivity of 0.85g/l/h after 2.5 hours of reaction, 5% higher than the 
productivity achieved with the single resin strategy in the conventional reactor 
configuration. This result supports the conclusion from Chapter 4 that there is a small 
improvement in the performance of the Baeyer-Villiger bioconversion using the dual 
resin strategy compared to the single resin strategy. 
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Table 5.1 Comparison of performance of three different strategies to undertake Baeyer 
Villiger bioconversion using two different reactor configurations- recycle reactor and 
conventional STR. 
  
Productivity 
(g/l/h) [vol. 
of aqueous 
phase+resins] 
Productivity 
(g/l/h) [vol. 
of aqueous 
phase only] 
Lactone on 
resin 
(g/gresin) 
Resin-free 
0.4g/l* N/A 1.80 N/A 
3g/l N/A 0.38 N/A 
Single: free in 
suspension 
L493 0.81 0.82 0.12 
Single: column L493 0.75 0.75 0.09 
Dual: free in 
suspension 
L493-IRC50 0.85 0.94 0.007 
XAD7-IRC50 0.76 0.84 0.005 
Dual resin: 
column 
L493-IRC50 0.70 0.78 0.005 
*performed to completion 
The data of the load of lactone on resins in Table 5.1 shows that lactone load on resin is 
significantly less when using the dual resin SFPR strategy compared to the use of the 
single resin SFPR strategy. This is because of the larger quantity of the second type of 
resin IRC50- used based on the adsorption kinetic studies- being needed to implement 
this system. 
The ratio of lactone concentration accumulated on IRC50 to lactone concentration 
accumulated on L493 (IRC50:L493) in the dual resin SFPR strategy using the recycle 
reactor configuration was 4.95g/g, demonstrating the suitability of this resin 
combination. 
Table 5.1 also shows the effect that the extra volume, as a result of the added resins, has 
on productivity by displaying, in column 4 the calculated productivities of the different 
bioconversions without taking the resin volume into account. 
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5.4 Conclusions 
This chapter applied the novel dual resin SFPR strategy, which was proven to increase 
productivity of a Baeyer Villiger bioconversion, by using two different configurations of 
a miniature stirred stank reactor system- namely the conventional reactor configuration 
where both types of resins were inside the STR and a recycle reactor configuration with 
one type of resin is housed in a miniature column. 
The recycle reactor configuration performed worse out of the two reactor configurations 
for both single resin and dual resin SFPR strategies however the dual resin SFPR 
strategy showed similar performance to the single resin SFPR strategy. Ideally 
separation of the different types of resins will allow for regeneration and reuse of the 
resins, an attractive proposition for industrial processes. 
As mentioned in the previous chapter, the shortcoming of the dual resin SFPR strategy 
was the higher amount of resin needed. This means that greater power is required for 
effective agitation of the resins for uniform distribution in the reactor. 
Overall, this investigation has set up a base for optimising the dual resin SFPR strategy 
at the small scale and has also opened the way for scale up studies. 
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Chapter 6. Overall Conclusions 
The research presented in this thesis is an evaluation of a novel dual resin substrate feed- 
product removal (SFPR) strategy by applying to the Baeyer-Villiger biooxidation 
reaction, catalysed by the recombinant E. coli TOP10 [pQR239]. Investigations began 
by performing adsorption studies to find the best combination of resins to implement in 
the dual resin SFPR strategy. Thereafter, ‘proof of concept’ was demonstrated for the 
dual resin SFPR strategy in shake flask experiments and then implementing it in two 
configurations using a miniature stirred tank reactor (STR). The key findings of this 
investigation are presented below: 
 Adsorption studies carried out at the ml-scale to characterise six resins found that 
the resin with the highest surface area, Dowex Optipore L493, possessed the 
highest maximum adsorption capacity for bicyclo[3.2.0]hept-2-en-6-one and 
(1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-2-one, the ketone substrate and lactone 
product of the Baeyer-Villiger bioconversion, respectively. These were 
determined as Qmax= 0.38g/gresin for ketone and Qmax= 0.15g/gresin for lactone 
after fitting adsorption data to the Langmuir and Freundlich adsorption models. 
 
 A high throughput resin screening (HTRS) was investigated as an alternative to 
carrying out adsorption studies at the ml-scale. Two platforms were chosen to 
perform the adsorption studies, namely the 96 wells and 24 wells microplates, 
the latter of which determined as the platform that produces more accurate 
adsorption results and models that fit those generated at the ml-scale. 
Additionally, significantly better resin suspension is achieved in the 24 wells 
microplate. 
 
 High throughput adsorption kinetics studies were performed in the 24 well 
microplate platform to determine selectivity of resins for ketone and the lactone 
compound, (1R,5S)-2-oxabicyclo[3.3.0]oct-6-en-3-one. Amberlite XAD7 was 
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found to have a higher selectivity for ketone over lactone and Amberlite IRC50 a 
higher selectivity for lactone over ketone than any other of the tested resins. 
 
 Resin combinations of L493-IRC50 and XAD7-IRC50 were used to implement 
the dual resin SFPR strategy in shake flask experiments, where resins L493 and 
XAD7 were utilised as the substrate feeding tools and IRC50 resin as the product 
removal tool. The amounts of L493 and XAD7 used were based on their capacity 
for ketone at an equilibrium concentration of 0.5g/l and were 0.21g/gresin and 
0.035g/gresin, respectively, to ensure aqueous substrate concentration during 
bioconversion was kept below the inhibitory concentration. The amount of 
IRC50 used was based on its maximum adsorption capacity for lactone, 
0.008g/gresin, to ensure complete removal of lactone product from the aqueous 
phase of the bioconversion. 
 
 Carrying out the Baeyer-Villiger bioconversion with the implementation of the 
dual resin SFPR strategy in shake flasks saw an increase of productivity 
compared to the Baeyer-Villiger bioconversions carried out without resins by as 
much as 132% and with the single resin SFPR strategy by as much 10%, thus 
demonstrating a ‘proof of concept’ of the novel dual resin SFPR bioconversion 
strategy. 
 
 Spatial separation of the two types of resins in the shake flask gave the 
opportunity to determine the proportion of the lactone product adsorbed onto 
resin Amberlite IRC50 which was used for product removal. 84% of total 
adsorbed lactone was adsorbed by IRC50 in the L493-IRC50 combination and 
89% of total adsorbed lactone in the XAD7-IRC50 combination was adsorbed by 
IRC50. This shows selectivity of IRC50 for the lactone product over the ketone 
substrate as determined in the HTRS adsorption kinetic studies. 
 
 The feasibility of implementing the dual resin SFPR strategy using a miniature 
reactor has also been demonstrated. A conventional stirred tank reactor (STR) 
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configuration, where both types of resins were added directly inside the STR, 
performed better than the recycle reactor configuration, where the resin used for 
substrate feeding was contained inside a miniature column. 
Productivities achieved with the single and dual resin SFPR strategies in the 
conventional reactor configuration were 0.82g/l/h and 0.94g/l/h, respectively. A 
comparison with the single resin SFPR strategy as performed by Hilker et al (2004a) in a 
bubble column reactor shows similar productivity of 1g/l/h to that achieved with the dual 
resin SFPR strategy. However comparison is not directly possible because of the 
differences in process conditions- Hilker et al (2004a) performed the adsorption 
isotherm studies at 25°C and the Baeyer-Villiger reaction in fermentation media, with a 
cell concentration of 6.4gDCW/l and at an initial substrate concentration of 25g/l, whereas 
in this research adsorption isotherm studies were carried out at 37°C, as this was the 
condition that the bioconversion was operated under, and bioconversions were 
performed in 50mM phosphate buffer, with a 8gDCW/l cell concentration and at an initial 
ketone concentration of 3g/l (thus requiring a lower amount of resin). Nonetheless, the 
similar performances of the single and dual resin SFPR bioconversion strategies as 
performed in this research shows a promise for large scale processing just as Hilker et al 
(2005) did with the single resin SFPR strategy, which has gone on to be industrially 
applied by Sigma-Aldrich. 
A shortcoming of implementing the dual resin SFPR strategy over the single resin SFPR 
strategy is the greater amount of resins required, due to the fact that two types of resin 
are required, one for substrate feeding and the other for product removal, rather than just 
the one type of resin that will perform both these roles in a single resin SFPR 
bioconversion. 
A cost analysis shows that it is more expensive to run the dual resin SFPR strategy that 
the single resin SFPR strategy based on the combinations of resins used in this research. 
It costs £17.39 per gram of substrate when using the L493-IRC50 combination and 
£20.27 per gram of substrate when using the XAD7-IRC50 combination for 
implementing the dual resin SFPR strategy. This is a stark contrast to the cost needed to 
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run the single resin SFPR strategy where a mere £0.06 per gram of substrate is required 
when utilising resin L493. (Costs have been based on quotes from Sigma-Aldrich). 
However, these costs are associated with the resins used in this research where the resin 
combinations were determined from screening six resins. Therefore by screening the 
vast number of resins available in the market, suitable resins that possess high 
adsorption capacities can off-set most of the cost as less will be needed to run the dual 
resin SFPR bioconversion strategy. The screening of hundreds of resins will be fast and 
efficient when done using the HTRS method developed from this research. 
Another challenge is seen with the use of non-specific commercial resins in the dual 
resin strategy. Although differences in selectivity for the substrate and product can be 
applied, the non-specific nature of the resins prevents complete selectivity for one 
compound over the other especially when both are structurally and chemically similar; 
as is in the case with the substrate and product of the Baeyer-Villiger reaction 
investigated. However differences between the ketone and lactone, such as the 3-
dimensional spatial arrangement of atoms and electron densities, can be exploited by 
designing resins specific to substrate and product, respectively. 
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Chapter 7. Future Work 
The work presented in this thesis set a good base for the optimisation and scale-up of the 
dual resin SFPR bioconversion strategy. Investigations should be conducted to improve 
efficiency of the high throughput resin screening (HTRS) and validation of the dual resin 
SFPR strategy will need to be performed if it is to be commercially implemented. 
Further detail of the aforementioned work is presented below. 
7.1 Automated HTRS and design of experiments (DoE) 
The adsorption studies performed and presented in Chapter 3 characterised only six 
resins, so carrying out screening of a wider range of resins will ensure validation of the 
HTRS method. The natural extension to this is the automation of the HTRS 
methodology. The first step is investigating a more efficient resin handling and 
dispensing system than manually weighing the resins. Figure 7.1 shows results for early 
experiments of investigating the accuracy of pipetting slurry of resins by using wide 
bore tips (Biohit, Sartorius, Finland). The advantage of this method of dispensing resins 
into microwells, apart from speeding up manual addition, allows this procedure and 
therefore adsorption studies to be automated with a Tecan Genesis platform (Tecan, 
Reading, UK) available in the Department of Biochemical Engineering, UCL. 
The HTRS can be further optimised by the use of design of experiments (DoE). This 
statistical approach will reduce the number of experiments and will maximise the quality 
of results gained from the HTRS. This is achieved by studying multiple experimental 
factors simultaneously as opposed to the ‘one factor at a time’ investigations, for 
example, factors such as temperature, solute concentration and time in the HTRS can be 
investigated simultaneously around a defined centre point. 
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Figure 7.1 Mass of resin Amberlite IRC50 dispensed by a wide bore tip as slurry from a 
10g/l resin suspension mixed by a 3 blade marine impeller at 350rpm. Error bars 
represent one standard deviation based on triplicate experiments. 
7.2 Scale up of the dual resin SFPR bioconversion strategy 
Implementation of the dual resin SFPR bioconversion strategy has opened the way for 
scale up studies in two reactor configurations- conventional and recycle reactors, thus 
criteria will need to be established that are required for larger scale designs of these two 
reactor configurations and then verification of the optimised process at pilot scale. There 
will be certain factors that are typically taken into consideration during reactor scale up 
but will be emphasised when scaling up a resin based SFPR bioconversion process, such 
as oxygen transfer and mixing. The extra volume that is added to the system as a result 
of using resins for performing the bioconversion will have an effect on other system 
requirements such as reactor size and considerations such cost per batch run. 
A study of the influence of scale up parameters such as hydraulic retention time, 
superficial velocity and bed dimensions is paramount for process performance and 
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design of a recycle reactor configuration. Also in order for the resin based SFPR 
bioconversion process to be applied in a commercial setting when using the recycle 
reactor configuration it is important to consider validation issues such as containment of 
the whole cell biocatalyst and the sterility of the process, because this configuration 
operates by the recycling of bioconversion medium through an external resin column 
and back to the reactor. 
An additional point to mention is the prospect for evaluation of the dual resin SFPR 
bioconversion strategy using a microscale platform and in fact an automated microscale 
platform based on recent research into rapid evaluation and optimisation of oxidative 
bioconversion processes using the Tecan Genesis platform has been developed recently 
(Baboo et al., 2012). 
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List of Abbreviations and Symbols 
Å Angstrom 
ATP Adenosine-5`-triphosphate 
BVMO Baeyer-Villger Monooxygenase 
Ceq Equilibrium concentration 
Ci Initial concentration 
CHMO Cyclohexanone Monooxygenase 
di Impeller diameter 
dT Reactor diameter 
DCM Dicholoromethane 
DCW Dry cell weight 
DoE Design of Experiments 
DOT Dissolved oxygen tension % 
DSW Deep square well 
FID Flame ionisation detector 
fps Frames per second 
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GC Gas chromatography 
HTRS High throughput resin screening 
ISPR in-situ product removal 
KA Langmuir isotherm equilibrium constant 
KF Freundlich isotherm equilibrium constant 
KK Initial rate of adsorption of ketone 
KL Initial rate of adsorption of lactone 
n Freundlich isotherm constant 
NAD Nicotinamide adenine dinucleotide (oxidised) 
NADH Nicotinamide adenine dinucleotide (reduced) 
M Mass of resin 
OD600nm Optical density measured at absorbance wavelength of  600nm 
OD Optical density 
psi Pound-force per square inch 
Qads Adsorption capacity 
Qmax Maximum adsorption capacity 
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R
2 
Regression coefficient 
rpm Revolutions per minute 
SK,L Selectivity 
SFPR Substrate feed-product removal 
STR Stirred tank reactor 
t Time 
U Enzyme unit defined as µmol of product formed per minute 
UV Ultraviolet 
V Total volume 
vvm Vessel volume per minute 
v/v Volume per volume 
w/v Weight per volume (g/ml) 
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Figure A.1 Calibration curves for ketone (●) and lactone (○) in ethyl acetate. Samples 
were prepared as described in section 2.2.1.1 and analysed as described in section 
2.2.1.2. Both fitted lines have R
2
 values >0.99 and error bars show one standard 
deviation based on triplicate experiments. 
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Figure A.2 Calibration of OD600nm measurements from an E. coli TOP10 [pQR239] 
fermentation with DCW measurements determined as described in section 2.2.2. Fitted 
line has an R
2
 value of > 0.99 and error bars represent one standard deviation based on 
triplicate experiments. 
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Figure A.3 Adsorption isotherms generated using XAD7 for the adsorption of (A) 
ketone (B) lactone in the 96 wells and 24 wells microplate platforms in experiments 
described in section 2.3.2.1. Black lines represent the Langmuir mathematical model 
fitted to the data as described in section 3.3.2 and the blue solid lines represent the 95% 
confidence interval band for the Langmuir model determined for adsorption at ml-scale 
(solid line: ml-scale; medium dashed line:96 wells; dotted line: 24 wells). 
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Figure A.4 Adsorption isotherms generated using IRC50 for the adsorption of (A) 
ketone (B) lactone in the 96 wells and 24 wells microplate platforms in experiments 
described in section 2.3.2.1. Black lines represent the Langmuir mathematical model 
fitted to the data as described in section 3.3.2 and the blue solid lines represent the 95% 
confidence interval band for the Langmuir model determined for adsorption at ml-scale 
(solid line: ml-scale; medium dashed line:96 wells; dotted line: 24 wells). 
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Figure A.5 Adsorption isotherms generated using L493 for the adsorption of (A) ketone 
(B) lactone in the 96 wells and 24 wells microplate platforms in experiments described 
in section 2.3.2.1. Black lines represent the Langmuir mathematical model fitted to the 
data as described in section 3.3.2 and the blue solid lines represent the 95% confidence 
interval band for the Langmuir model determined for adsorption at ml-scale (solid line: 
ml-scale; medium dashed line:96 wells; dotted line: 24 wells). 
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Figure A.6 Adsorption isotherms generated using XAD4 for the adsorption of (A) 
ketone (B) lactone in the 96 wells and 24 wells microplate platforms in experiments 
described in section 2.3.2.1. Black lines represent the Langmuir mathematical model 
fitted to the data as described in section 3.3.2 and the blue solid lines represent the 95% 
confidence interval band for the Langmuir model determined for adsorption at ml-scale 
(solid line: ml-scale; medium dashed line:96 wells; dotted line: 24 wells). 
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Figure A.7 Adsorption isotherms generated using XAD16 for the adsorption of (A) 
ketone (B) lactone in the 96 wells and 24 wells microplate platforms in experiments 
described in section 2.3.2.1. Black lines represent the Langmuir mathematical model 
fitted to the data as described in section 3.3.2 and the blue solid lines represent the 95% 
confidence interval band for the Langmuir model determined for adsorption at ml-scale 
(solid line: ml-scale; medium dashed line:96 wells; dotted line: 24 wells). 
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Figure A.8 Adsorption isotherms generated using XAD1180 for the adsorption of (A) 
ketone (B) lactone in the 96 wells and 24 wells microplate platforms in experiments 
described in section 2.3.2.1. Black lines represent the Langmuir mathematical model 
fitted to the data as described in section 3.3.2 and the blue solid lines represent the 95% 
confidence interval band for the Langmuir model determined for adsorption at ml-scale 
(solid line: ml-scale; medium dashed line:96 wells; dotted line: 24 wells). 
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Figure A.9 Production of lactone by E. coli TOP10 [pQR239] biocatalyst (8gDCW/l) 
using initial ketone concentration of 0.4g/l in (●) 50mM phosphate buffer (working 
volume 10%) and (○) fermentation media (working volume 20%), without the use of a 
resin SFPR strategy as described in section 2.5.1. Error bars represent one standard 
deviation based on triplicate repeats of experiments. 
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Figure A.10 Characterisation of the peristaltic Pump P-1 (Pharmacia Biotech, Sweden) 
by passing 50mM phosphate buffer through the Tricorn 5/50 column (GE Healthcare, 
Buckinghamshire, UK) packed with 1.2g of resin Optipore L493.(●) setting x1 and (○) 
setting x10. Error bars represent one standard deviation based on triplicate repeats of 
experiments. 
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Figure A.11 Flow rate of 8gDCW/l of cells resuspended in 50mM phosphate buffer 
passed through the Tricorn 5/50 column (GE Healthcare, Buckinghamshire, UK) packed 
with 1.2g of resin Optipore L493 using the the peristaltic Pump P-1 (Pharmacia Biotech, 
Sweden) at a flow rate of 6.4ml/min. Error bars represent one standard deviation based 
on triplicate repeats of experiments. 
 146 
 
FigureA.12 Mechanical drawing of a cross section of the miniature stirred tank reactor 
(taken from Gill et al 2008). 
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Figure A.13 Calculated mass balances from all bioconversions performed in the 
miniature STR without resins (‘0.4g/l’ and ‘3g/l’), with the single resin SFPR strategy in 
the conventional reactor (‘L493 (conventional reactor)’) and recycle reactor (‘L493 
(recycle reactor)’) configurations and with the dual resin SFPR strategy in the 
conventional reactor (‘L493-IRC50 (conventional reactor)’ and ‘XAD7-IRC50 
(conventional reactor)’) and recycle reactor (‘L493-IRC50 (recycle reactor)’) 
configurations. Results after 2.5 hours of bioconversion. 
